Drage koleginice i kolege, dragi prijatelji, Veliko je - Savez ...
06.01.2013 • Views
Share Embed Flag

Drage koleginice i kolege, dragi prijatelji, Veliko je - Savez ...

Drage koleginice i kolege, dragi prijatelji, Veliko je - Savez ...

Drage koleginice i kolege, dragi prijatelji, Veliko je - Savez ...

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
farmacija.org

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

<strong>Drage</strong> <strong>koleginice</strong> i <strong>kolege</strong>,<br />

<strong>dragi</strong> <strong>prijatelji</strong>,<br />

<strong>Veliko</strong> <strong>je</strong> zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbi<strong>je</strong> sa<br />

međunarodnim učešćem u Beogradu. Kongres se održava u organizaciji Farmaceutskog društva<br />

Srbi<strong>je</strong> i saradnji sa Farmaceutskim fakultetom Univerziteta u Beogradu, Farmaceutskom<br />

Komorom Srbi<strong>je</strong> i Agencijom za lekove i medicinska sredstva Srbi<strong>je</strong>.<br />

Zadovoljstvo nam <strong>je</strong> da su se pozivu odazvali istaknuti stručnjaci iz zeml<strong>je</strong> i inostranstva, kao i<br />

predstavnici farmaceutskih i srodnih fakulteta, farmaceutske industri<strong>je</strong> i međunarodnih<br />

stručnih udruženja. Učestvovan<strong>je</strong> <strong>je</strong> prijavilo više od 1500 farmaceuta i stručnjaka iz srodnih<br />

profesija, iz 14 zemalja.<br />

Naučni rad na Kongresu odvijaće se u okviru plenarnih predavanja, 11 uvodnih sekcijskih<br />

predavanja, 13 predavanja po pozivu, 33 usmena izlaganja, više od 220 poster prezentacija, tri<br />

mini simpozijuma, dve panel diskusi<strong>je</strong> i okruglog stola.<br />

Veru<strong>je</strong>mo da će Kongres pružiti priliku za stican<strong>je</strong> novih znanja u farmaceutskim naukama i<br />

farmaceutskoj praksi, i omogućiti dragocenu razmenu iskustva sa kolegama iz inostranstva u<br />

cilju unapređenja kompetentnosti.<br />

Takođe, iskreno se nadamo da ćete uživati u lepoti oktobarskih dana u Beogradu.<br />

Želimo Vam uspešan rad i prijatan boravak.<br />

Dear colleagues and friends,<br />

It is our great pleasure and privilege to welcome you at the Fifth Congress of pharmacist of<br />

Serbia with international participation in Belgrade. The Congress is organized by<br />

Pharmaceutical Society of Serbia in collaboration with Faculty of Pharmacy, University of<br />

Belgrade, Pharmaceutical Chamber of Serbia and Agency for Medicinal Products and Medical<br />

Devices of Serbia.<br />

We are glad that our invitation has been accepted by outstanding specialists from Serbia and<br />

abroad, leading colleagues from pharmaceutical and related faculties, pharmaceutical industry<br />

and international professional organization. More than 1500 pharmacists and specialists from<br />

related professions, from 14 countries have been registered.<br />

Scientific work at the Congress is held as plenary lecture, 11 introductory lectures within<br />

sections, 33 oral presentations, more than 220 poster presentations, three mini symposiums,<br />

two panel discussions and the round table.<br />

We believe the Congress will provide you with the opportunity to be updated on the advances of<br />

the pharmaceutical science and innovative pharmacy practice. It will also provide you with a<br />

beneficial exchange of international experiences in order to advance competencies.<br />

Also, we sincerely hope you will enjoy your stay and Octobers days in Belgrade.<br />

We wish you success in your work and pleasant stay.<br />

Prof. dr Ivanka Miletić<br />

Predsednik Organizacionog Odbora<br />

President of Organizing Committee<br />

Prof. dr Branislava Miljković<br />

Predsednik Naučnog Odbora<br />

President of Scientific Committee

Naučni odbor<br />

Scientific Committee<br />

Predsednik / President<br />

Branislava Miljković<br />

Članovi / Members<br />

Gordana Vuleta<br />

Vesna Matović<br />

Vesna Spaso<strong>je</strong>vić-Kalimanovska<br />

Ljiljana Tasić<br />

Slađana Šobajić<br />

Radica Stepanović-Petrović<br />

Mira Zečević<br />

Silvana Petrović<br />

Zorica Vujić<br />

Jelena Parojčić<br />

Stephen Hudson<br />

Atilla Hincal<br />

Stane Srčič<br />

Antonia Trichopoulou<br />

Teresa Kowalska<br />

Tehnička podrška<br />

Technical support<br />

Mirjana Anđić<br />

Dragica Stupar<br />

Organizacioni odbor<br />

Organizing Committee<br />

Predsednik / President<br />

Ivanka Miletić<br />

Članovi / Members<br />

Brižita Đorđević<br />

Vesela Radonjić<br />

Dragana Jovanović<br />

Dubravka Urošev<br />

Ivana Popović<br />

Slavica Radović<br />

Miroslav Turnić<br />

Đurđina Jeličić<br />

Ana Živec Simić<br />

Zoran Savković<br />

Lusija Avedisijan<br />

Aleksandar Janković<br />

Ivana Trifunović<br />

Srđan Malešev<br />

Izvršni organizator<br />

Executive Organizer<br />

Smart Travel

Naučno-stručni rad na kongresu odvija se u okviru sledećih sekcija:<br />

Scientific work at the Congress is held in the following sections:<br />

Farmaceutska zdravstvena zaštita - apotekarska delatnost (FZZ - APO)<br />

Pharmaceutical care -community pharmacy (FZZ - APO)<br />

Farmaceutska zdravstvena zaštita - bolnička farmacija (FZZ-BOL)<br />

Pharmaceutical care - hospital pharmacy (FZZ - BOL)<br />

Farmakoinformatika (FI)<br />

Pharmacoinformatics (FI)<br />

Farmaceutska tehnologija i kozmetologija (FTK)<br />

Pharmaceutical technology and cosmetology (FTK)<br />

Farmakoekonomija (FE)<br />

Pharmacoeconomics (FE)<br />

Ispitivan<strong>je</strong> i kontrola lekova (IKL)<br />

Drug analysis and quality control (IKL)<br />

Lekovito bil<strong>je</strong> (LB)<br />

Medicinal plants (LB)<br />

Toksikološka i sanitarna hemija (TSH)<br />

Toxicological and sanitary chemistry (TSH)<br />

Medicinska biohemija (MB)<br />

Medical biochemistry (MB)

PROGRAM / PROGRAMME<br />

Sreda, 13. oktobar 2010. / Wednesday, October 13th, 2010<br />

18:00-21:00 Svečano otvaran<strong>je</strong> / Opening ceremony<br />

Plenarno predavan<strong>je</strong> / Plenary lecture<br />

Misija farmaci<strong>je</strong> u javnom zdravlju / Pharmacy's mission in contributing to public health<br />

Prof Stephen Hudson, Strathclyde Institute of Pharmacy and Biomedical Sciences,<br />

University of Strathclyde, Great Britain<br />

th<br />

Četvrtak, 14. oktobar 2010. / Thursday, October 14 , 2010<br />

09:00-11:30<br />

09:00-09:30<br />

09:30-10:00<br />

10:00-10:15<br />

10:15-10:30<br />

10:30-10:45<br />

10:45-11:00<br />

CENTRALNA DVORANA / CENTRAL HALL<br />

SEKCIJA ZA FARMACEUTSKU ZDRAVSTVENU ZAŠTITU-APOTEKARSKA<br />

DELATNOST (FZZ - APO)<br />

PHARMACEUTICAL CARE - COMMUNITY PHARMACY SECTION (FZZ - APO)<br />

Drug related problems in elderly patients<br />

Prof Ulrich Jaehde, Institute of Pharmacy, Department of Clinical<br />

Pharmacy, University of Bonn, Germany<br />

Euro public health needs and the correct educational response from the<br />

profession<br />

Prof Ian Bates, School of Pharmacy, University of London, Great Britain<br />

Razvoj kompetencija u pružanju farmaceutske zdravstvene zaštite - da<br />

li smo spremni?<br />

Competency development in pharmaceutical care – are we ready?<br />

Arijana Meštrović, Edukacijski centar Atlantic Farmacia, Zagreb, Hrvatska<br />

Koliko su paci<strong>je</strong>nti informisani o bezbednosnim aspektima preparata<br />

koji se izdaju bez lekarskog recepta?<br />

How well are patients informed about safety aspects of over-the-counter<br />

medicines?<br />

Sandra Vezmar, Jasmina Jevtić Ranđelović, Mirjana Marković, Jelena Gigov,<br />

Branislava Miljković<br />

Uloga farmaceuta u pravovremenom otkrivanju osoba ko<strong>je</strong> imaju<br />

faktore rizika za osteoporozu<br />

The role of the pharmacist in timely identification of persons with<br />

osteoporosis risk factors<br />

Tatjana Milošević<br />

Pravilnom upotrebom inhalatora do postizanja optimalnog terapijskog<br />

ishoda astme<br />

Appropriate use of inhalers for achieving optimal therapeutic outcome of<br />

asthma<br />

Roland Antonić, Sandra Vezmar, Milica Pešić, Snežana Lukić

11:00-11:30<br />

12:00-13:00<br />

13:00-13:30<br />

13:30-14:30<br />

13:30-14:30<br />

13:30-14:00<br />

14:00-14:30<br />

14:30-15:00<br />

Diskusija / Discussion<br />

PRVA GALERIJA / THE FIRST GALLERY<br />

Poster prezentaci<strong>je</strong> sekcija FZZ - APO, FI i MB<br />

Poster presentations of sections FZZ - APO, FI and MB<br />

Diskusija o odabranim poster prezentacijama sekcija FZZ - APO, FI i<br />

MB<br />

Discussion on sections poster presentations FZZ - APO, FI and MB<br />

ANEKS B / ANEX B<br />

Mini simpozijum Agenci<strong>je</strong> za lekove i medicinska sredstva Srbi<strong>je</strong><br />

Mini symposium organized by the Agency for Medicinal Products and<br />

Medical Devices<br />

Razvoj farmakovigilance i uspostavljan<strong>je</strong> sistema vigilance za<br />

medicinska sredstva u Republici Srbiji<br />

Pharmacovigilance development and establishment of vigilance for<br />

medical devices in the Republic of Serbia<br />

Predavači/Lecturers: Tatjana Šipetić, Marija Petroni<strong>je</strong>vić, Jelena Pilić,<br />

Marko Erić, Aleksandra Vujačić Simić<br />

ANEKS A / ANEX A<br />

Panel diskusija: Upravljan<strong>je</strong> farmaceutskim otpadom<br />

Panel discussion: Managing pharmaceutical waste<br />

Moderatori/moderators: Ljiljana Tasić, Vukica Kocić Pešić, Jelena<br />

Manojlović, Tanja Arsić<br />

CENTRALNA DVORANA / CENTRAL HALL<br />

Satelitski simpozijum/Satelitte symposium<br />

Alkaloid<br />

Suplementacija vitaminom C - Da li <strong>je</strong> uvek više bol<strong>je</strong>?<br />

Vitamin C supplementation – Is more always better?<br />

Predavač/Lecturer: Prof. dr Branimir Nestorović<br />

Satelitski simpozijum/Satelitte symposium Berlin Chemie<br />

Fitoterapija benigne hiperplazi<strong>je</strong> prostate (BPH)<br />

Phytotherapy of benign prostatic hyperplasia (BPH)<br />

Predavač/Lecturer: Dr sc. Zoran Maksimović, Farmaceutski fakultet u<br />

Beogradu<br />

Satelitski simpozijum/Satelitte symposium Berlin Chemie<br />

Nove mogućnosti za terapiju akutnog bola<br />

New properties for treatment of accute pain<br />

Predavač/Lecturer: Prof. dr Slobodan Apostolski, Medicinski fakultet<br />

Beograd

15:00 -15:30<br />

15:30-18:00<br />

15:30-16:00<br />

16:00-16:30<br />

16:30-17:00<br />

17:00-17:30<br />

17:30-18:00<br />

18:00-18:30<br />

Satelitski simpozijum/Satelitte symposium<br />

Richter Gedeon<br />

Tolperison-hidrohlorid: izazov u farmakoterapiji mišićnog spazma<br />

Tolperison-hydrochloride: challenge in the pharmacotherapy of muscle<br />

spasms<br />

Predavač/Lecturer: Ass Marija Milinković, Farmaceutski fakultet u<br />

Beogradu<br />

CENTRALNA DVORANA / CENTRAL HALL<br />

SEKCIJA ZA FARMAKOINFORMATIKU (FI)<br />

PHARMACOINFORMATICS SECTION (FI)<br />

Uloga endotela u vaskularnim efektima eritropoetina<br />

Role of endothelium in vascular effect of erythropoietin<br />

Prof. dr Zvonimir Katušić, Mayo Clinic, Minnesota, SAD<br />

Polimikrobne infekci<strong>je</strong><br />

Polymicrobial infections<br />

Prof. dr Milorad Pavlović, Klinika za infektivne bolesti KCS Beograd,<br />

Medicinski fakultet, Univerzitet u Beogradu<br />

Spirala stresa u somatskim i mentalnim poremećajima<br />

The spiral of stress in physical and mental disorders<br />

Prof. dr Dušica Lečić-Toševski, Jelena Stepanović, Olivera Vuković,<br />

Medicinski fakultet, Univerzitet u Beogradu<br />

Savremeni aspekti u lečenju atrijalne fibrilaci<strong>je</strong><br />

Contemporary treatment of atrial fibrillation<br />

Dr sci Tatjana Potpara, Klinika za kardiologiju, Klinički centar Srbi<strong>je</strong><br />

Diskusija / Discussion<br />

CENTRALNA DVORANA / CENTRAL HALL<br />

Satelitski simpozijum/Satelitte symposium MSD<br />

NOVI PROIZVODI NOVOG MSD-a<br />

NEW PRODUCTS OF THE NEW MSD<br />

Nuvaring - korak dal<strong>je</strong> za savremenu ženu<br />

Nuvaring – a step forward for the modern woman<br />

Dr Zoran Stanković, Institut za zdravstvenu zastitu majke i deteta<br />

"Dr Vukan Čupić"

15:00-18:00<br />

15:30-16:00<br />

16:00-16:30<br />

16:30-16:45<br />

16:45-17:00<br />

17:00-17:15<br />

17:15-17:30<br />

17:30-18:00<br />

Arcoxia - Preuzmite kontrolu bola<br />

Arcoxia – Take over the pain management<br />

Dr Predrag Ostojić, Institut za reumatologiju, Beograd<br />

AMFITEATAR / AMPHITHEATER<br />

SEKCIJA ZA MEDICINSKU BIOHEMIJU (MB)<br />

MEDICAL BIOCHEMISTRY SECTION (MB)<br />

Oksidativni stres i ateroskleroza<br />

Oxidative stress and atherosclerosis<br />

Doc dr Jelena Kotur-Stevul<strong>je</strong>vic, Katedra za Medicinsku biohemiju,<br />

Farmaceutski fakultet, Univerzitet u Beogradu, Srbija<br />

Procena dijagnostickih procedura i novih biomarkera: koncept i<br />

metode analize odnosa troskova i efektivnosti<br />

Assessment of diagostic procedures and new biomarkers: the concept<br />

and methods of cost-effectiveness analysis<br />

Natasa Bogavac-Stano<strong>je</strong>vic, Zorana Jelic-Ivanovic, Slavica Spasic, Jelena<br />

Kotur-Stevul<strong>je</strong>vic, Violeta Dopsaj, Dragana Lakic, Katedra za Medicinsku<br />

biohemiju, Farmaceutski fakultet, Univerzitet u Beogradu, Srbija<br />

Veza izmedu koncentraci<strong>je</strong> N-terminalnog fragmenta B-tipa<br />

natriuretskog peptida i dijastolne disfunkci<strong>je</strong> leve komore kod<br />

paci<strong>je</strong>nata sa renalnim transplantom<br />

Association of N-terminal pro B-type natriuretic peptide with left<br />

ventricular diastolic dysfunction in patients with renal transplant<br />

Lidija Memon, Natasa Bogavac-Stano<strong>je</strong>vic, Vesna Spaso<strong>je</strong>vic<br />

Kalimanovska, Sanja Simic-Ogrizovic, Violeta Dopsaj, Jelena Kotur-<br />

Stevul<strong>je</strong>vic<br />

Uticaj pola i starosti na koncentraci<strong>je</strong> holesterola i apolipoproteina B<br />

u malim gustim LDL cesticama<br />

Effect of gender and age on cholesterol and apolipoprotein B<br />

concentrations in small, dense LDL particles<br />

Jelena Vekic, Aleksandra Zeljkovic, Zorana Jelic-Ivanovic, Vesna<br />

Spaso<strong>je</strong>vic-Kalimanovska, Lidija Memon, Slavica Spasic<br />

Prirodna autoantitela su znacajan pokazatelj neprogresivne HIV<br />

infekci<strong>je</strong><br />

The natural autoantibodies are a significant marker in non-progressive<br />

HIV infection<br />

Ana Đorđević-Vujičić, Milena Veljković, Ursula Dietrich, Maria Sakarellos<br />

Daitsiotis, Sanja Glišić, Nevena Veljković<br />

Uticaj dve metode za izolaciju RNK na nivo genske ekspresi<strong>je</strong> enzima<br />

SOD-1 i SOD-2 u humanoj krvi<br />

Effects of two RNA isolation methods on SOD-1 and SOD-2 gene expression<br />

levels in human blood<br />

Ana Vujovic, Vesna Spaso<strong>je</strong>vic-Kalimanovska, Natasa Bogavac<br />

Stano<strong>je</strong>vic, Slavica Spasic, Jelena Kotur-Stevul<strong>je</strong>vic<br />

Diskusija / Discussion

th<br />

Petak, 15. oktobar 2010. / Friday, October 15 , 2010<br />

09:00-11:30<br />

09:00-09:30<br />

09:30-09:50<br />

09:50-10:10<br />

10:10-10:25<br />

10:25-10:40<br />

10:40-10:55<br />

10:55-11:30<br />

12:00-13:30<br />

AMFITEATAR / AMPHITHEATER<br />

SEKCIJA ZA FARMAKOEKONOMIJU (FE)<br />

PHARMACOECONOMICS SECTION (FE)<br />

Challenges and Opportunities for Pharmacy: Current Practice<br />

Cognitive Services and Economics<br />

Prof Martin Schulz, RPh, PhD, FFIP, ABDA, Department of Medicine,<br />

Berlin, and Goethe University Frankfurt, Germany<br />

Nacionalna infrastruktura kvaliteta - osnov za pristup EU i slobodnoj<br />

trgovini lekovima<br />

National quality infrastructure - basis for access to the EU and free<br />

trade of medicines<br />

Gordana Pejović, Jovan Filipović i Ljiljana Tasić<br />

KIDSCREEN-52 upitnik za procenu kvaliteta života kod dece i<br />

adolescenata: Prvi psihometrijski rezultati za srpsku verziju<br />

The KIDSCREEN-52 Quality of Life Measure for Children and<br />

Adolescents: The first Psychometric Results from Serbian version<br />

Tanja Novaković, Dejan Stevanović, Aneta Lakić, Darija Kisić<br />

Tepavčević<br />

Odnos propisivanja anksiolitika i antidepresiva u Srbiji<br />

The anxiolytic/antidepressant prescribing ratio in Serbia<br />

Nevena Divac, Zoran Todorović, Radan Stojanović, Zorica Nešić,<br />

Branislava Medić, Milica Prostran<br />

Farmakoekonomski modeli u farmaciji sa prim<strong>je</strong>rima nesteroidnih<br />

antireumatika<br />

Pharmacoeconomics models in pharmacy with examples of non<br />

steroid antirheumatics<br />

Armin Škrbo, Vera Dabanović<br />

Promene cena lekova sa liste lekova koji idu na teret Fonda za<br />

zdravstveno osiguran<strong>je</strong> Makedoni<strong>je</strong> nakon uvođenja referentnih<br />

cena za nabavku lekova<br />

Changes in the prices of medicines from the medicines list reimbursed by<br />

the Health insurance fund in Republic of Macedonia after the<br />

implementation of reference pricing for medicine procurement<br />

Bistra Angelovska, Verica Ivanovska<br />

Diskusija / Discussion<br />

Skupština farmaceutskog društva Srbi<strong>je</strong><br />

Assembly of Pharmaceutical Society of Serbia

09:00-11:30<br />

09:00-09:30<br />

09:30-10:00<br />

10:00-10:30<br />

10:30-11:00<br />

11:00-11:30<br />

11:30-12:00<br />

12:00-13:00<br />

13:00-13:30<br />

13:30-14:30<br />

CENTRALNA DVORANA / CENTRAL HALL<br />

SEKCIJA ZA ISPITIVANJE I KONTROLU LEKOVA (IKL)<br />

DRUG ANALYSIS AND QUALITY CONTROL (IKL)<br />

In vitro chiral instability of selected carboxylic acids: experimental<br />

evidence and possible pathways<br />

Teresa Kowalska, Institute of Chemistry, University of Silesia, Katowice,<br />

Poland<br />

LC-MS/MS: a powerful means in bioanalysis<br />

Yannis Dotsikas, PhD, School of Pharmacy, University of Athens, Athens,<br />

Greece<br />

Recent studies of drug molecules by x-ray crystallography and Raman<br />

spectroscopy<br />

Babur Z. Chowdhry, School of Science, University of Greenwich, Great<br />

Britain<br />

Amorphous materials: pharmaceutical importance, detection an<br />

characterisation<br />

Milan D. Antoni<strong>je</strong>vić, School of Science, University of Greenwich, Great<br />

Britain<br />

Studi<strong>je</strong> forsirane degradaci<strong>je</strong> različitih generičkih lekova<br />

Study of forced degradation of several generic drugs<br />

Marija Pavlović, Agencija za lekove i medicinska sredstva Srbi<strong>je</strong>,<br />

Beograd, Srbija<br />

Diskusija / Discussion<br />

PRVA GALERIJA / THE FIRST GALLERY<br />

Poster prezentaci<strong>je</strong> sekcija FE, IKL i FZZ - BOL<br />

Poster presentations of sections FE, IKL and FZZ - BOL<br />

Diskusija o odabranim poster prezentacijama sekcija FE, IKL i FZZ -<br />

BOL<br />

Discussion on poster presentations of sections FE, IKL, FZZ - BOL<br />

ANEKS A / ANEX A<br />

Panel diskusija / Panel Discussion<br />

Usaglašavan<strong>je</strong> nacionalne regulative sa regulativom Evropske Uni<strong>je</strong><br />

u oblasti lekova i medicinskih sredstava<br />

Harmonization of national legislation with EU legislation in the field of<br />

medicines and medical devices<br />

Mrs Tijana Radojčić, Ministarstvo zdravlja Republike Srbi<strong>je</strong>, Odsek za<br />

lekove i medicinska sredstva

13:30-14:30<br />

14:30-15:00<br />

15:00-15:30<br />

15:30-18:00<br />

15:30-16:00<br />

16:00-16:30<br />

16:30-16:45<br />

ANEKS B / ANEX B<br />

Panel diskusija / Panel discussion<br />

Akutna trovanja lekovima<br />

Drug Poisoning<br />

Uvodna rec / Introduction: Vesna Matovic, Snezana Dordevic,Andelka<br />

Spasic<br />

CENTRALNA DVORANA / CENTRAL HALL<br />

Mini simpozijum Farmaceutske Komore Srbi<strong>je</strong><br />

Mini symposium organized by the Pharmaceutical Chamber of Serbia<br />

Kontinuirana edukacija - analiza <strong>je</strong>dnogodisn<strong>je</strong>g iskustva<br />

Continuing education - analysis of one year experience<br />

(Ucesnici / participants: Dragana Jovanovic, Jela Milic, Gordana Simic,<br />

Mirjana Antunovic, Dragana Sovtic, Predrag Petrovic)<br />

CENTRALNA DVORANA / CENTRAL HALL<br />

Satelitski simpozijum/Satellite Symposium<br />

Galenika<br />

Inoviran<strong>je</strong> proizvodnog programa – profesionalni izazov i odgovornost<br />

farmaceutske industri<strong>je</strong><br />

Innovation of the production programme – a professional challenge and<br />

responsibility of the pharmaceutical industry<br />

Prim.dr sc.ph. Suzana Miljkovic, Galenika a.d. - Beograd<br />

CENTRALNA DVORANA / CENTRAL HALL<br />

SEKCIJA ZA FARMACEUTSKU ZDRAVSTVENU ZASTITU - BOLNICKA<br />

FARMACIJA (FZZ-BOL)<br />

PHARMACEUTICAL CARE - HOSPITAL PHARMACY SECTION (FZZ - BOL)<br />

Professional goals in applying pharmaceutical science to clinical<br />

practice<br />

Prof Stephen Hudson, Strathclyde Institute of Pharmacy and Biomedical<br />

Sciences, University of Strathclyde, Velika Britanija<br />

Klinicki farmaceuti: uloga i odgovornost (SHPA asocijacija bolnickih<br />

farmaceuta Australi<strong>je</strong>)<br />

Clinical pharmacists: role and responsibilities (as per SHPA society of<br />

hospital pharmacists of Australia)<br />

Jasminka Nikola<strong>je</strong>vic-Sarunac, Senior Pharmacist, Pharmacy<br />

Department, John Hunter Hospital, New Lambton Heights, Australia<br />

Aktivnosti udruzenja bolnickih farmaceuta na nivou Evropske uni<strong>je</strong><br />

Activities of hospital pharmacists association in European Union<br />

Tajda Miharija Gala, University Medical Centre Ljubljana, Slovenia

16:45-17:00<br />

17:00-17:15<br />

17:15-17:30<br />

17:30-18:00<br />

18.00-19.00<br />

15:30-18:00<br />

15:30-16:00<br />

16:00-16:20<br />

16:20-16:40<br />

Značaj podataka dobi<strong>je</strong>nih tokom terapijskog monitoringa<br />

karbamazepina i valproinske kiseline u optimizaciji terapi<strong>je</strong><br />

epilepsi<strong>je</strong> uz primenu populacione farmakokinetičke analize<br />

The importance of therapeutic drug monitoring data in optimization of<br />

epilepsy therapy with carbamazepine and valproic acid using population<br />

pharmacokinetic approach<br />

Katarina Vučićević, Branislava Miljković, Milena Pokrajac, Iztok Grabnar,<br />

Milica Prostran, Ružica Veličković, Žarko Martinović<br />

Propisivan<strong>je</strong> humanih albumina u ginekološko-акušerskoj klinici<br />

„Narodni Front“ u periodu od 2004-2009 godine<br />

The use of human albumins in the Clinic of gynecology and obstetrics<br />

“Narodni Front” in the period 2004-2009<br />

Svetlana Ristić, Lenka Kostovska-Mićević, Lazar Pa<strong>je</strong>vić, Maja Vasić,<br />

Dušan Stano<strong>je</strong>vić<br />

Uloga bolničkog farmaceuta u racionalnoj terapiji antibioticima<br />

Role of hospital pharmacist in rational therapy with antibiotics<br />

Milan Tomić, Dragana Rajinac, Marija Kara- Jovanović, Gordana Jevtić,<br />

Marina Klančnik, Ljubica Stojičević<br />

Diskusija / Discussion<br />

CENTRALNA DVORANA / CENTRAL HALL<br />

Satelitski simpozijum / Satelitte Symposia<br />

Sanofi Aventis d.o.o.<br />

Klinička farmacija-od izazova do mogućnosti/Clinical Pharmacy<br />

from challenges to opportunities<br />

Moderator: Prof. Branislava Miljković, Farmaceutski fakultet Beograd<br />

Predavači-praktičari: Mr.ph.Jelena Milovanović-Delić, London<br />

Mr.ph. Maxime Japkowicz, Pariz<br />

AMFITEATAR / AMPHITHEATER<br />

SEKCIJA ZA FARMACEUTSKU TEHNOLOGIJU I KOZMETOLOGIJU (FTK)<br />

PHARMACEUTICAL TECHNOLOGY AND COSMETOLOGY SECTION (FTK)<br />

Betulsions - an innovative formulation concept for emulsifier free w/o<br />

emulsions<br />

Rolf Daniels and Marta K. Grysko, Department of Pharmaceutical<br />

Technology, Eberhard Karls University Tübingen, Germany<br />

Primena optimizacionih tehnika zasnovanih na veštačkoj inteligenciji<br />

u razvoju farmaceutskih proizvoda<br />

Artificial intelligence in pharmaceutical product formulation<br />

Svetlana Ibrić, Farmaceutski fakultet, Univerzitet u Beogradu<br />

Uvećan<strong>je</strong> veličine šarži interaktivnih smeša praškova<br />

Pharmaceutical process scale-up for interactive powder mixtures<br />

Ljiljana Harding

16:40-16:55<br />

16:55-17:10<br />

17:10-17:25<br />

17:25-17:40<br />

17:40-17:50<br />

17:50-18:00<br />

Study of the uniformity of the coating thickness of pellets coated by<br />

Wurster and swirl flow generator equipped coater<br />

Matevž Luštrik, Rok Dreu, Stane Srčič<br />

Primena in silico metoda u razvoju formulacija čvrstih farmaceutskih<br />

oblika<br />

Application of in silico methods in formulation development of solid<br />

pharmaceutical dosage forms<br />

Jelena Petrović, Svetlana Ibrić, Gabriele Betz, Zorica Đurić<br />

Značaj proučavanja osobina po<strong>je</strong>dinačnih polimernih molekula za<br />

razumevan<strong>je</strong> svojstava ksantan matriks tableta<br />

Importance of xanthan single molecular properties for understanding<br />

behavior of the matrix tablets<br />

Biljana Govedarica, Saša Baumgartner, Stane Srčič<br />

Predviđan<strong>je</strong> sadržaja aktivne supstance u intaktnim tabletama<br />

upotrebom NIR spektroskopi<strong>je</strong> i multivarijantne analize podataka<br />

Prediction of drug content in intact tablets using NIR spectroscopy and<br />

multivariate data analysis methods<br />

Branko Vranić, Gabriele Betz<br />

Uticaj kontaktne ambalaže na in-use stabilnost hloramfenikol kapi za<br />

oči<br />

The effects of packaging on the in-use stability of Chloramphenicol eye<br />

drops<br />

Nataša Đorđević Filijović, Sanja Kovačević Radonić, Borislava Gavrilov,<br />

Nada Marinković<br />

Diskusija / Discussion

th<br />

Subota, 16. oktobar 2010. / Saturday, October 16 , 2010<br />

09:00-11:30<br />

09:00-09:30<br />

09:30-10:00<br />

10:00-10:15<br />

10:15-10:30<br />

10:30-10:45<br />

10:45-11:00<br />

AMFITEATAR / AMPHITHEATER<br />

SEKCIJA ZA LEKOVITO BILJE (LB)<br />

MEDICINAL PLANTS SECTION (LB)<br />

Cimicifuga racemosa: od fitohemi<strong>je</strong> do klinike<br />

Black cohosh (Cimicifuga racemosa): from phytochemistry to the clinic<br />

Dr Dejan Nikolić, Department of Medicinal Chemistry and<br />

Pharmacognosy, College of Pharmacy, University of Illinois at Chicago,<br />

SAD<br />

Bioaktivni sastojci nekih samoniklih biljaka Srbi<strong>je</strong> i Crne Gore<br />

Bioactive constituents of some wild-growing plants from Serbia and<br />

Montenegro<br />

Prof. dr Slobodan Milosavl<strong>je</strong>vić, Hemijski fakultet Univerziteta u<br />

Beogradu i Centar za hemiju (IHTM), Beograd<br />

Antioksidantna aktivnost metanolnih ekstrakata Thymus pannonicus<br />

All. (Lamiaceae) sa nekoliko lokaliteta u Srbiji<br />

Antioxidant activity of methanol extracts of Thymus pannonicus All.<br />

(Lamiaceae) from several localities in Serbia<br />

Jelena Arseni<strong>je</strong>vić, Jelena Živković, Ivan Šoštarić, Zoran Maksimović<br />

Hemijski sastav, antimikrobna, antiradikalska i spazmolitička<br />

aktivnost etarskih ulja Ferula heuffelii Griseb. ex Heuffel (Apiaceae)<br />

Chemical composition, antimicrobial, antiradical and spasmolytic<br />

activity of Ferula heuffelii Griseb. ex Heuffel (Apiaceae) essential oils<br />

Ivan Pavlović, Silvana Petrović, Marina Milenković, Mirjana Radenković,<br />

Suzana Branković, Maria Couladis, Milica Pavlović-Drobac<br />

Medicinski potencijal ekstrakta Allium rotundum subsp. waldsteinii,<br />

Alliaceae<br />

Health properties of extract of wild garlic (Allium rotundum subsp.<br />

waldsteinii, Alliaceae)<br />

Biljana Božin, Neda Lakić, Isidora Samojlik, Neda Mimica-Dukić, Ružica<br />

Igić<br />

Plantago coronopus L. kao potencijalni izvor prirodnih<br />

antioksidantnih i antiinflamatornih agenasa<br />

Plantago coronopus L. as a potential natural antioxidant and anti<br />

inflammatory agent<br />

Ivana Beara, Marija Lesjak, Dejan Orčić, Nataša Simin, Goran Anačkov,<br />

Neda Mimica-Dukić

11:00-11:15<br />

11:15-11:30<br />

9:00-11:30<br />

09:00-09:30<br />

09:30-10:00<br />

10:00-10:30<br />

10:30-11:00<br />

11:00-11:30<br />

12:00-13:00<br />

13:00-13:30<br />

13:30-15:00<br />

Uloga farmaceuta u savetovanju paci<strong>je</strong>nata sa benignom<br />

hiperplazijom prostate<br />

The role of pharmacists in advising the patients with benign prostatic<br />

hyperplasia<br />

Mira Stojanović, Zoran Maksimović<br />

Diskusija / Discussion<br />

CENTRALNA DVORANA / CENTRAL HALL<br />

SEKCIJA ZA FARMAKOINFORMATIKU (FI)<br />

PHARMACOINFORMATICS SECTION(FI)<br />

Lekovi koji utiču na sistem renin-angiotenzin-aldosteron<br />

Drugs affecting the renin-angiotensin-aldosterone system<br />

Prof. dr Nenad Ugrešić, Katedra za farmakologiju, Farmaceutski<br />

fakultet, Univerzitet u Beogradu<br />

Rezistencija na klopidogrel<br />

Clopidogrel resistance<br />

Prof. dr Radica Stepanović-Petrović, Katedra za farmakologiju,<br />

Farmaceutski fakultet, Univerzitet u Beogradu<br />

Statini: vreme za nove indikaci<strong>je</strong> ili za nove nežel<strong>je</strong>ne efekte?<br />

The statins: time for new indications or for new adverse effects?<br />

Doc. dr Miroslav Savić, Katedra za farmakologiju, Farmaceutski<br />

fakultet, Univerzitet u Beogradu<br />

Ivabradin – novi lek u terapiji stabilne angine<br />

Ivabradine – novel drug in treatment of stable angina<br />

Doc. dr Maja Tomić, Katedra za farmakologiju, Farmaceutski fakultet,<br />

Univerzitet u Beogradu<br />

Diskusija / Discussion<br />

PRVA GALERIJA / THE FIRST GALLERY<br />

Poster prezentaci<strong>je</strong> sekcija LB, FTK i TSH<br />

Poster presentations of sections LB, FTK and TSH<br />

Diskusija o odabranim poster prezentacijama sekcija LB, FTK i TSH<br />

Discussion on poster presentations of sections LB, FTK and TSH<br />

CENTRALNA DVORANA / CENTRAL HALL<br />

Okrugli sto: Aktuelnosti iz farmaceutske struke (predstavnici<br />

Farmaceutskog fakulteta, Ministarstva zdravlja,<br />

Farmaceutskog društva Srbi<strong>je</strong>, Farmaceutske komore<br />

Srbi<strong>je</strong>...<br />

Round table: News from the pharmaceutical profession (representatives<br />

of the Faculty of Pharmacy, Ministry of Health,<br />

Pharmaceutical Society of Serbia, Pharmaceutical<br />

Chamber of Serbia...)

15:30-18:00<br />

15:30-16:00<br />

16:00-16:20<br />

16:20-16:40<br />

16:40-16:55<br />

16:55-17:10<br />

17:10-17:25<br />

17:25-17:40<br />

17:40-18:00<br />

CENTRALNA DVORANA / CENTRAL HALL<br />

SEKCIJA ZA FARMACEUTSKU TEHNOLOGIJU I KOZMETOLOGIJU (FTK)<br />

PHARMACEUTICAL TECHNOLOGY AND COSMETOLOGY SECTION (FTK)<br />

Novel applications of surfactants in pharmacy<br />

Christel C. Müller-Goymann, Institut für PharmazeutischeTechnologie,<br />

Technische Universität Braunschweig, Germany<br />

Preparation, characterisation and application of smart polymeric<br />

particles<br />

Martin J. Snowden and Joanna B. Thorne, School of Science, University<br />

of Greenwich, United Kingdom<br />

Biološka raspoloživost i bezbednost primene dermatoloških lekova i<br />

dermokozmetičkih proizvoda: metode za in vitro i in vivo procenu<br />

Bioavailability and safety of dermatological drugs and dermocosmetic<br />

products: methods of in vitro/in vivo evaluation<br />

Snežana Savić, Farmaceutski fakultet, Univerzitet u Beogradu<br />

Ne-emulgujući i samo-(mikro)emulgujući lipidni nosači lekovitih<br />

supstanci<br />

Non-emulsifying and self-(micro)emulsifying drug delivery systems<br />

Ljiljana Đekić, Marija Primorac<br />

Uticaj vrste biodegradabilnog polimera na submikronske čestice sa<br />

ketoprofenom – ispitivan<strong>je</strong> fizičkih karakteristika i efikasnosti<br />

inkapsulaci<strong>je</strong> li<strong>je</strong>ka<br />

Influence of biodegradable polymer type on ketoprofen loaded sub<br />

micron particles - study of physical characterization and drug<br />

encapsulation efficiency<br />

Sonja Vučen, Gordana Vuleta, Nenad Ignjatović, Dragan Uskoković<br />

Efikasnost kozmetičkih proizvoda – ko<strong>je</strong> efekte <strong>je</strong> moguće ispitati i<br />

kako?<br />

Efficacy evaluation of cosmetic products - which effects can be<br />

measured and how?<br />

Milica Lukić, Ivana Jakšić, Gordana Vuleta<br />

Status i bezbednost nanokozmetičkih proizvoda<br />

Nanocosmetics - legal status and health risks<br />

Gordana Vuleta, Radava Korać, Snežana Savić<br />

Diskusija / Discussion

15:30-18:00<br />

15:30-16:00<br />

16:00-16:30<br />

16:30-17:00<br />

17:00-17:30<br />

17:30-18:00<br />

18:00-18:30<br />

AMFITEATAR / AMPHITHEATER<br />

SEKCIJA ZA TOKSIKOLOŠKU HEMIJU I SEKCIJA ZA SANITARNU HEMIJU<br />

(TSH)<br />

TOXICOLOGICAL AND SANITARY CHEMISTRY SECTION (TSH)<br />

Xenobiotic/Drug metabolizing enzyme polymorphisms: their role in<br />

response to chemotherapy and survival in lung cancer<br />

Prof Mumtaz Iscan, Department of Toxicology, Faculty of Pharmacy,<br />

Ankara University, Turska<br />

Mediterranean diet and health<br />

Prof Antonia Trichopoulou, Department of Hygiene and Epidemiology,<br />

School of Medicine, University of Athens, Grčka<br />

Budućnost nanomedicine?<br />

Future of nanomedicine?<br />

Prof. Mirjana Đukić, Katedra za toksikologiju „Akademik Danilo<br />

Soldatović“ Farmaceutskog fakulteta Univerziteta u Beogradu<br />

Di<strong>je</strong>tetski proizvodi i dodaci ishrani - nova regulativa<br />

Food for particular nutritional uses and food supplements – new<br />

regulation<br />

Prof. Ivan Stanković, Katedra za bromatologiju Farmaceutskog<br />

fakulteta Univerziteta u Beogradu, Srbija<br />

Diskusija / Discussion<br />

AMFITEATAR / AMPHITHEATER<br />

Zatvaran<strong>je</strong> Kongresa / Closing word<br />

th<br />

Nedelja, 17. oktobar 2010. / Sunday, October 17 , 2010<br />

Biće organizovani izleti zavisno od zainteresovanosti učesnika:<br />

Sremski Karlovci, Resava-Manasija, Topola-Aranđelovac, Smederevska tvrđava.<br />

Svi autobusi polaze sa parkinga Sava centra (savska strana)<br />

Prijava za izlete i preuziman<strong>je</strong> vouchera, najkasni<strong>je</strong> do 14. oktobra u 14:00h na Registracionom pultu.<br />

Informaci<strong>je</strong>: Turistička agencija SMART.<br />

Congress tours will be organized depending on the participants interest:<br />

Sremski Karlovci, Resava-Manasija, Topola-Aranđelovac, Smederevo Fortress.<br />

Departure of buses: parking area in front of Sava Center (riverside).<br />

Registration for excursions and issue of vouchers: Registration Desk, 14th October at 14.00 the latest.<br />

Information: Travel Agency SMART.

th<br />

Četvrtak, 14. oktobar 2010. / Thursday, October 14 , 2010<br />

09:00-18:00<br />

12:00-13:00<br />

13:00-13:30<br />

POSTER SEKCIJA / POSTER SECTION<br />

Poster prezentaci<strong>je</strong> sekcija FZZ – APO, FI i MB<br />

Poster presentations of sections FZZ – APO, FI and MB<br />

Prisustvo autora<br />

Presence of authors<br />

Diskusija o odabranim poster prezentacijama sekcija FZZ – APO, FI i MB<br />

Discussion on poster presentations of sections FZZ – APO, FI and MB<br />

SEKCIJA ZA FARMACEUTSKU ZDRAVSTVENU ZAŠTITU – APOTEKARSKA<br />

DELATNOST (FZZ – APO)<br />

PHARMACEUTICAL CARE – COMMUNITY PHARMACY SECTION (FZZ – APO)<br />

FZZ-APO-1 TELEPHONE INTERVENTION BY COMMUNITY PHARMACY IMPROVES MEDICATION<br />

COMPLIANCE<br />

Dragoslav Dupalo, PharmD, Beatrixapotheek Den Helder, The Netherlands<br />

FZZ-APO-2 INFORMISANOST RODITELJA O BOLESTI DISAJNIH PUTEVA U DECE<br />

PARENTS AWARENESS ABOUT RESPIRATORY DIESEASES IN CHILDREN<br />

Gordana Tanasi<strong>je</strong>vić, Marija Pešić<br />

FZZ-APO-3 PROCENA PRAVILNE PRIMENE TERAPIJE OD STRANE PACIJENATA U TRETMANU<br />

HRONIČNOG KANCERSKOG BOLA<br />

EVALUATION OF APPROPRIATE ADMINISTRATION OF CHRONIC CANCER PAIN<br />

THERAPY BY PATIENTS<br />

Ivana Baričić, Eva Koči<br />

FZZ-APO-4 UPUTSTVO ZA LEK U SLUŽBI PACIJENTA<br />

PATIENT INFORMATION LEAFLET IN THE SERVICE OF THE PATIENT<br />

Katarina Tešić-Sti<strong>je</strong>pović,Olga Bogo<strong>je</strong>vić,Dragana Radovanović<br />

FZZ-APO-5 REZULTATI ANKETE O POZNAVANJU NEŽELJENIH REAKCIJA NA LEKOVE OD<br />

STRANE PACIJENATA<br />

RESULTS OF THE SURVEY ON THE KNOWLEDGE OF ADVERSE DRUG REACTIONS<br />

BY PATIENTS<br />

Mika Simišić, Dani<strong>je</strong>la Dobrosavl<strong>je</strong>vić, Sandra Vranić<br />

FZZ-APO-6 UPOTREBA, INTERAKCIJE I NEŽELJENA DEJSTVA INHIBITORA PREUZIMANJA<br />

SEROTONINA<br />

THE USE, INTERACTIONS AND ADVERSE EFFECTS OF SELECTIVE SEROTONIN<br />

REUPTAKE INHIBITORS<br />

Milan Čarapić

FZZ-APO-7 LEKOVI KOJI SE NAJVIŠE IZDAJU NA LEKARSKI RECEPT U APOTEKARSKOJ<br />

JEDINICI PAPAZOVAC U SMEDEREVU<br />

DRUGS THAT ARE MOST ISSUED ON PRESCRIPTION IN THE PARMACEUTICAL UNIT<br />

PAPAZOVAC IN SMEDEREVO<br />

Milena Slavković<br />

FZZ-APO-8 INFORMISANOST PACIJENATA O URGENTNOJ KONTRACEPCIJI<br />

HOW WELL ARE OUR PATIENTS INFORMED ABOUT EMERGENCY CONTRACEPTION?<br />

Milica Pešić, Gordana Stanisavl<strong>je</strong>vić, Jasmina Arsić, Roland Antonić, Kristina<br />

Dimić, Sandra Vezmar<br />

FZZ-APO-9 ADHERENCIJA TERAPIJI OSTEOPOROZE<br />

ADHERENCE TO OSTEOPOROSIS THERAPY<br />

Nataša Radosavl<strong>je</strong>vić, Zoran Radosavl<strong>je</strong>vić, Predrag Vukomanović<br />

FZZ-APO-10 NOVA ULOGA TALIDOMIDA-PRAĆENJE PROPISIVANJA<br />

NEW ROLE OF THALIDOMIDE-FOLLOWING PRESCRIPTIONS<br />

Nataša Stefanović<br />

FZZ-APO-11 EDUKATIVNA ULOGA FARMACEUTA U SPREČAVANJU NEŽELJENIH DEJSTAVA<br />

NESTERODINIH ANTIINIFLAMATORNIH LEKOVA<br />

EDUCATIONAL ROLE OF PHARMACIST IN PREVENTING ADVERSE EFFECTS OF<br />

NONSTEROIDAL ANTIINFLAMMATORY DRUGS<br />

Predrag Vukomanović, Nataša Radosavl<strong>je</strong>vić, Zoran Radosavl<strong>je</strong>vić<br />

FZZ-APO-12 UTICAJ PREPORUKE APOTEKARA NA ODLUKU PACIJENTA O IZBORU LEKOVA KOJI<br />

SE IZDAJU BEZ LEKARSKOG RECEPTA<br />

IMPACT OF PHARMACIST'S RECOMMENDATION ON PATIENT'S PURCHASE DECISION,<br />

IN OVER-THE-COUNTER PHARMACY MARKET IN SERBIA<br />

Sanja Ivanović<br />

FZZ-APO-13 PRIKAZ REZULTATA INTERVJUA PACIJENATA LEČENIH OD OSTEOPOROZE<br />

SPROVEDENIH U APOTECI “DR. SIMA MILOŠEVIĆ” U BEOGRADU<br />

THE REVIEW OF THE RESULTS BASED ON INTERVIEW WITH PATIENTS TREATED<br />

FOR OSTEOPOROSIS IN PHARMACY “DR. SIMA MILOŠEVIĆ” IN BELGRADE<br />

Slavica Nikolić<br />

FZZ-APO-14 DA LI SU PACIJENTI DOVOLJNO INFORMISANI O PRIMENI LEKOVA KOJI SE IZDAJU<br />

BEZ LEKARSKOG RECEPTA?<br />

ARE PATIENTS WELL ENOUGH INFORMED ABOUT OVER-THE-COUNTER MEDICINES?<br />

Snežana Živanović, Sandra Vezmar<br />

FZZ-APO-15 UPOTREBA FOLNE KISELINE TOKOM PRVOG TRIMESTRA TRUDNOĆE U SRBIJI<br />

USE OF FOLIC ACID DURING THE FIRST TRIMESTER OF PREGNANCY IN SERBIA<br />

Sonja Stojiljković<br />

FZZ-APO-16 FARMACEUT U APOTECI-ZABORAVLJENI ČLAN U TIMU ZDRAVSTVENE ZAŠTITE?<br />

PHARMACIST-THE FORGOTTEN MEMBER OF HEALTH CARE TEAM?<br />

Vesna Đorđević

FZZ-APO-17 KOMPLIJANSA KOD PACIJENATA SA BENIGNOM HIPERPLAZIJOM PROSTATE<br />

COMPLIANCE IN PATIENTES WITH BENIGN PROSTATIC HYPERPLASIA<br />

Zoran Radosavl<strong>je</strong>vić, Nataša Radosavl<strong>je</strong>vić, Predrag Vukomanović<br />

FZZ-APO-18 PRIMENA INFORMACIONIH TEHNOLOGIJA U PROMOCIJI ZDRAVLJA U APOTECI<br />

SUBOTICA<br />

APPLICATION OF INFORMATION TECHNOLOGY IN HEALTH PROMOTION IN<br />

PHARMACY SUBOTICA<br />

Aleksandar Malagurski, Jelena Blažin, Sandra Ćupić<br />

FZZ-APO-19 SAŽETAK KARAKTERISTIKA LEKA (SMPC) - INFORMACIJE NAMENJENE ZDRAVSTVENIM<br />

RADNICIMA<br />

SUMMARY OF PRODUCT CHARACTERISTICS (SMPC) –INFORMATION<br />

FOR HEALTH PROFESSIONALS<br />

Jasmina Bašić, Katarina Kovačević, Danka Tešić, Tanja Neđić, Vladan Savić<br />

FZZ-APO-20 ANALIZA AKTIVNOSTI APOTEKE SUBOTICA U PROMOCIJI JAVNOG ZDRAVLJA<br />

ANALYSIS OF PUBLIC HEALTH PROMOTION ACTIVITIES CONDUCTED BY<br />

PHARMACY SUBOTICA<br />

Tatjana Crnjanski, Svetlana Rudinski-Stojkov, Ljiljana Tasić, Ivana Tadić,<br />

Dušanka Krajnović, Andrijana Milošević<br />

FZZ-APO-21 UTICAJ PONAŠANJA FARMACEUTA NA ADHERENCU<br />

INFLUENCE OF PHARMACIST BIHAVIOR ON ADHERENCE<br />

Dragana Jocić, Dušanka Krajnović<br />

FZZ-APO-22 PRUŽANJE SPECIFIČNE FARMACEUTSKE USLUGE NA PRIMERU APOTEKE VRŠAC<br />

PROVIDING SPECIFIC PHARMACY SERVICE – CASE STUDY PHARMACY VRŠAC<br />

Stana Tirnanić, Ivana Tadić<br />

FZZ-APO-23 STAVOVI FARMACEUTA O KOMPLIJANSI U REGIONIMA SRBIJE<br />

THE PHARMACISTS' ATTITUDES ON COMPLIANCE IN THE REGIONS OF SERBIA<br />

Ivana Tadić, Svetlana Stojkov-Rudinski, Tatjana Crnjanski, Ljiljana Tasić<br />

FZZ-APO-24 ASPEKTI ŽIVOTNE SREDINE I UPRAVLJANJE FARMACEUTSKIM OTPADOM U<br />

APOTECI BEOGRAD<br />

ENVIRONMENTAL ASPECTS AND MANAGEMENT OF PHARMACEUTICAL WASTE IN<br />

BELGRADE<br />

Milanković Rade, Jović Sanja<br />

FZZ-APO-25 ULOGA APOTEKE U ZBRINJAVANJU STARIH LEKOVA IZ DOMAĆINSTAVA<br />

THE ROLE OF PHARMACY IN MANGEMENT OF OLD DRUGS IN HOUSEHOLDS<br />

Jelena Manojlović, Sunčica Todorović, Filip Todorović

FZZ-APO-26 UPRAVLJANJE FARMACEUTSKIM OTPADOM – STAVOVI KORISNIKA APOTEKE SUBOTICA<br />

PHARMACEUTICAL WASTE MANAGEMENT – THE ATTITUDES OF PHARMACY<br />

SUBOTICA'S PATIENTS<br />

Svetlana Stojkov-Rudinski, Ivana Tadić, Jasmina Vukša, Bojana Zrnić,<br />

Ljiljana Tasić, Dušanka Krajnović<br />

SEKCIJA ZA FARMAKOINFORMATIKU (FI)<br />

PHARMACOINFORMATICS SECTION (FI)<br />

FI–1 LOKALNO PERIFERNO ANALGETIČKO DEJSTVO LEVETIRACETAMA JE<br />

POSREDOVANO ALFA2-ADRENERGIČKIM RECEPTORIMA<br />

THE INVOLVEMENT OF ALPHA2-ADRENOCEPTORS IN THE LOCAL PERIPHERAL<br />

ANALGESIC EFFECT OF LEVETIRACETAM<br />

Ana Micov, Maja Tomić, Radica Stepanović-Petrović<br />

FI–2 ULOGA GABA A RECEPTORA KOJI SADRŽE ΑLFA1 PODJEDINICU U RAZVOJU<br />

MOTORNE INKOORDINACIJE PRI PRIMENI DIAZEPAMA<br />

CONTRIBUTION OF ALPHA1 SUBUNIT-CONTAINING GABA A RECEPTORS TO<br />

DIAZEPAM-INDUCED MOTOR IMPAIRMENT<br />

Jovana Divljaković, Marija Milinković, Tamara Timić, Srđan Joksimović,<br />

Miroslav Savić<br />

FI-3 VAZORELAKSANTNI EFEKAT NIKORANDILA NA IZOLOVANOJ HUMANOJ<br />

UNUTRAŠNJOJ MAMILARNOJ ARTERIJI<br />

THE VASORELAXANT EFFECTS OF NICORANDIL IN THE ISOLATED HUMAN<br />

INTERNAL MAMMARY ARTERY<br />

Marija Pavlović, Aleksandra Novaković, Miodrag Perić, Milan Babić, Milan Ćirković,<br />

Slavica Ristić, Ljiljana Gojković Bukarica<br />

FI–4 FARMAKOLOŠKO ISPITIVANJE 3-KARBOMETOKSI FENTANILA U MIŠEVA<br />

PHARMACOLOGICAL EVALUATION OF 3-CARBOMETHOXY FENTANYL IN MICE<br />

Sonja Vučković, Milica Prostran, Katarina Savić Vujović, Zorica Nešić, Milovan<br />

Ivanović, Ljiljana Došen-Mićović<br />

FI–5 ANTIARITMIJSKA TERAPIJA KOD BOLESNIKA SA ATRIJALNOM FIBRILACIJOM<br />

ANTIARRHYTHMIC DRUG THERAPY IN ATRIAL FIBRILLATION<br />

Tatjana Potpara, Marija Polovina, Gordana Potpara-Marković<br />

FI -6 ZNAČAJ UPUTSTVA ZA LEK U INFORMACIONOM DRUŠTVU<br />

THE IMPORTANCE OF PATIENT INFORMATION LEAFLET IN THE INFORMATION<br />

SOCIETY<br />

Danka Tešić, Tanja Neđić, Katarina Kovačević, Jasmina Bašić, Vladan Savić<br />

FI–7 PROCEDURA MEĐUSOBNOG PRIZNAVANJA (MRP) I DECENTRALIZOVANA<br />

PROCEDURA (DCP) ZA REGISTRACIJU LEKOVA U EU<br />

MUTUAL RECOGNITION PROCEDURE (MRP) AND DECENTRALISED PROCEDURE (DCP)<br />

FOR REGISTRATION OF MEDICINAL PRODUCTS IN EU<br />

Zorica Pejčić, Tanja Neđić

FI–8 BOLNIČKA POTROŠNJA CEFALOSPORINA<br />

CEHPALOSPORINS HOSPITAL CONSUMPTION<br />

Jelena Brusić-Renaud, Mirjana Antunović<br />

FI–9 PROCENA INFORMISANOSTI SRPSKIH VRHUNSKIH SPORTISTA O DOPINGU<br />

EVALUATION OF THE INFORMATION LEVEL ON DOPING WITH HIGH LEVEL<br />

SERBIAN ATHLETES<br />

Dušan Antić, Sergej Ostojić<br />

FI-10 THE ROLE OF THE PHARMACOINFORMATICS IN THE IMPROVEMENT OF THE<br />

PHARMACEUTICAL CARE<br />

Maja Kovaceva, Jasminka Patceva, Biljana Lazarova, Lidija Petrusevska Tozi,<br />

Kristina Mladenovska<br />

FI–11 STATISTIČKI POKAZATELJI O PREVENCIJI, LIJEČENJU I INFORMISANOSTI O RAKU<br />

VRATA MATERNICE U BOSNI I HERCEGOVINI<br />

STATISTICAL INDICATORS ON PREVENTION, TREATMENT AND AWARENESS OF<br />

CERVICAL CANCER IN BOSNIA AND HERZEGOVINA<br />

Armin Škrbo, Dženita Bajrambašić, Selma Škrbo<br />

FI-12 NOVOREGISTROVANI LEKOVI U REPUBLICI SRBIJI<br />

THE NEWLY REGISTERED DRUGS IN THE REPUBLIC OF SERBIA<br />

Tatjana Kolarska, Marija Janković<br />

FI-13 FARMACEUTSKI ZDRAVSTVENI RADNICI U ZDRAVSTVENOM SISTEMU REPUBLIKE<br />

SRBIJE<br />

THE PHARMACEUTICAL HEALTH PROFESSIONALS IN THE RS HEALTH SYSTEM<br />

Tatjana Kolarska, Anđelka Dželetović<br />

FI-14 CENTAR ZA INFORMACIJE O LEKOVIMA- ANALIZA POZIVA KORISNIKA<br />

DRUG INFORMATION CENTER - USER CALLS ANALYSIS<br />

Nikola Radunović<br />

SEKCIJA ZA MEDICINSKU BIOHEMIJU (MB)<br />

MEDICAL BIOCHEMISTRY SECTION (MB)<br />

MB-1 OŠTEĆENJE DNK ISPITIVANO KOMETA ESEJOM PRE I NAKON SUPLEMENTACIJE<br />

ASTAKSANTINOM KOD FUDBALERA<br />

DNA DAMAGE DETECTED BY THE COMET ASSAY BEFORE AND AFTER ASTAXANTHIN<br />

SUPPLEMENTATION IN FOOTBALL PLAYER<br />

Miron Sopić, Nataša Bogavac-Stano<strong>je</strong>vić, Ivana Baralić, Brižita Đorđević,<br />

Jelena Kotur - Stevul<strong>je</strong>vić, Zorana Jelić – Ivanović<br />

MB-2 PROMENE U AKTIVNOSTI I FENOTIPSKOJ DISTRIBUCIJI ENZIMA PARAOKSONAZE 1<br />

U TOKU NORMALNE TRUDNOĆE<br />

CHANGES OF PARAOXONASE ACTIVITY AND PARAOXONASE PHENOTYPE<br />

DISTRIBUTION THROUGHOUT NORMAL PREGNANCY<br />

Aleksandra Stefanović, Jelena Kotur-Stevul<strong>je</strong>vić, Dani<strong>je</strong>la Ardalić,Vesna<br />

Mandić-Marković, Željko Miković, Slavica Spasić

MB-3 CHARACTERIZATION OF N-LINKED OLIGOSACCHARIDES IN IMMUNOREACTIVE<br />

GLYCOPROTEINS FROM PERIPHERAL NERVE AND CAMPYLOBACTER JEJUNI O:19<br />

Ana Poceva-Panovska, Katerina Brezovska, Aleksandra Grozdanova, Ljubica<br />

Suturkova, Slobodan Apostolski<br />

MB-4 RASPODELE LDL I HDL SUBFRAKCIJA I KLINIČKI ZNAČAJ NJIHOVOG ODREĐIVANJA<br />

U RAZLIČITIM BOLESTIMA POVEZANIM SA RAZVOJEM ATEROSKLEROZE<br />

DISTRIBUTIONS OF LDL AND HDL SUBFRACTIONS AND CLINICAL SIGNIFICANCE OF<br />

THEIR ASSESSMENT IN VARIOUS ATHEROSCLEROSIS-RELATED DISEASES<br />

Aleksandra Zeljković, Jelena Vekić, Vesna Spaso<strong>je</strong>vić-Kalimanovska,<br />

Zorana Jelić-Ivanović, Nataša Bogavac-Stano<strong>je</strong>vić, Aleksandra Stefanović<br />

MB-5 POVEZANOST BIOHEMIJSKIH I HISTOLOŠKIH PROMENA KOD ISHEMIJSKO-<br />

REPERFUZIJSKOG OŠTEĆENJA BUBREGA U EKSPERIMENTALNOM MODELU<br />

RELATIONSHIP BETWEEN BIOCHEMICAL AND HISTOPATHOLOGICAL FINDINGS<br />

DURING ISCHEMIA / REPERFUSION KIDNEY INJURY IN EXPERIMENTAL RAT MODEL<br />

Zorica Nešić, Zoran Todorović, Branislava Medić, Gordana Basta-Jovanović,<br />

Nevena Divac, Milica Prostran<br />

MB-6 FARMAKOVIGILANCA I HEMOVIGILANCA KOD LEKOVA DOBIJENIH IZ HUMANE PLAZME<br />

PHARMACOVIGILANCE AND HAEMOVIGILANCE IN STABILE PRODUCTS DERIVED<br />

FROM HUMAN PLASMA<br />

Marija Romić<br />

MB-7 OKSIDATIVNO-STRESNI STATUS PACIJENATA SA SARKOIDOZOM I KORELACIJA SA<br />

KLINIČKIM PARAMETRIMA<br />

OXIDATIVE STRESS STATUS IN SARCOIDOSIS PATIENTS AND CORRELATION WITH<br />

CLINICAL PARAMETERS<br />

Jasmina Ivanišević, Jelena Kotur-Stevul<strong>je</strong>vić, Aleksandra Stefanović, Zorana<br />

Jelić-Ivanović, Slavica Spasić, Violeta Vučinić-Mihailov<br />

MB-8 PARAMETRI OKSIDATIVNOG STRESA I ANTIOKSIDATIVNE ZAŠTITE KOD PACIJENATA<br />

SA SHIZOFRENIJOM<br />

PARAMETERS OF OXIDATIVE STRESS AND ANTIOXIDATIVE PROTECTION IN PATIENTS<br />

WITH SCHIZOPHRENIA<br />

Bojana Vidović, Brižita Đorđević , Jelena Kotur-Stevul<strong>je</strong>vić, Aleksandra<br />

Stefanović, Čedo Mil<strong>je</strong>vić, Dušica Lečić-Toševski<br />

MB-9 REAKTIVNI PROTEINSKI KARBONILI U PRAĆENJU OKSIDATIVNOG STRESA KOD<br />

PACIJENATA NA HEMODIJALIZI<br />

REACTIVE PROTEIN CARBONYLS FOR MONITORING OXIDATIVE STRESS IN<br />

HEMODIALYSIS PATIENTS<br />

Jasmina Pavičić, Jelena Kotur-Stevul<strong>je</strong>vić, Tatjana Ivanić-Ćorlomanović,<br />

Aleksandra Stefanović, Ana Vujović, Vesna Spaso<strong>je</strong>vić-Kalimanovska<br />

MB-10 TOTALNI OKSIDANTNO – ANTIOKSIDANTNI STATUS KOD PACIJENATA SA<br />

KORONARNOM ARTERIJSKOM BOLEŠĆU<br />

TOTAL OXIDATIVE – ANTIOXIDANT STATUS IN CORONARY ARTERY DISEASE PATIENTS<br />

Aleksandra Vukašinović, Dragica Ristić, Jelena Kotur-Stevul<strong>je</strong>vić, Vesna<br />

Spaso<strong>je</strong>vić-Kalimanovska, Slavica Spasić, Aleksandra Stefanović

th<br />

Petak, 15. oktobar 2010. / Friday, October 15 , 2010<br />

09:00-18:00<br />

12:00-13:00<br />

13:00-13:30<br />

Poster prezentaci<strong>je</strong> sekcija IKL, FZZ – BOL<br />

Poster presentations of sections IKL and FZZ – BOL<br />

Prisustvo autora<br />

Presence of authors<br />

Diskusija o odabranim poster prezentacijama sekcija IKL, FZZ – BOL<br />

Discussion on poster presentations of sections IKL and FZZ – BOL<br />

SEKCIJA ZA ISPITIVANJE I KONTROLU LEKOVA (IKL)<br />

DRUG ANALYSIS AND QUALITY CONTROL SECTION (IKL)<br />

IKL-1 OBELEŽAVANJE PAKOVANJA LEKA: USAGLAŠENOST SA REGULATORNIM ZAHTEVIMA<br />

MEDICINAL PRODUCT LABELLING: COMPLIANCE WITH REGULATORY REQUIREMENTS<br />

Gordana Žigić, Sv<strong>je</strong>tlana Mihaljica<br />

IKL-2 DERIVATI PLAZME -STABILNI LEKOVI IZ KRVI REGULATORNI ASPEKT<br />

PLASMA - DERIVED MEDICINAL PRODUCTS REGULATORY REQUIREMENTS<br />

Vesna Popržen, Sv<strong>je</strong>tlana Mihaljica<br />

IKL-3 PRAĆENJE SOLVOLIZE NOVIH ESTARSKIH DERIVATA FLUOCINOLON ACETONIDA I<br />

POREĐENJE SA FLUOCINONIDOM PRIMENOM DERIVATIVNE UV<br />

SPEKTROFOTOMETRIJE I RP-HPLC – IN VITRO MODEL ZA AKTIVIRANJE PREDLEKA<br />

SOLVOLYSIS OF A NOVEL ESTER DERIVATIVES OF FLUOCINOLONE ACETONIDE IN<br />

COMPARISON WITH FLUOCINONIDE ASSAYED BY UV DERIVATIVE<br />

SPECTROPHOTOMETRY AND RP-HPLC – IN VITRO MODEL SYSTEM FOR PRODRUG<br />

ACTIVATION<br />

Bojan Marković, Sote Vladimirov, Olivera Čudina,Vladimir Savić,<br />

Katarina Karljiković-Rajić<br />

IKL-4 RAZVOJ BIORELATIVNOG TESTA ZA PRAĆENJE BRZINE RASTVARANJA<br />

KLOPIDOGRELA IZ TABLETA SA TRENUTNIM OSLOBAĐANJEM NA OSNOVU IN VITRO<br />

REZULTATA<br />

EVALUATION OF BIORELEVANT IN VITRO TEST FOR CLOPIDOGREL IMMEDIATE<br />

RELEASE TABLETS BASED ON IN VIVO RESULTS<br />

Aleksandra Spasić, Maja Stojanović, Irena Homšek<br />

IKL-5 OBELEŽAVANJE HEDP ITRIJUMOM-90 ZA TERAPIJU METASTAZA U KOSTIMA<br />

LABELLING OF HEDP WITH 90Y FOR THE TREATMENT OF BONE METASTASES<br />

Dragana Stanković, Drina Janković, Nadežda Nikolić, Sanja Vran<strong>je</strong>š-Đurić,<br />

Pavle Glodić, Magdalena Lazarević

IKL-6 ODREĐIVANJE LIZINOPRILA U HUMANOJ PLAZMI METODOM HPLC I PRIMENA U<br />

STUDIJI BIOEKVIVALENCIJE<br />

QUANTITATIVE DETERMINATION OF LISINOPRIL IN HUMAN PLASMA BY HPLC<br />

METHOD AND ITS APPLICATION IN A BIOEQIVALENCE STUDY<br />

Rumenka Petkovska, Aneta Dimitrovska, Liljana Ugrinova, Liljana Labacevska-<br />

Gjatovska, Nikola Labacevski<br />

IKL-7 VIŠESTRUKA IN VITRO/IN VIVO KORELACIJA NIVOA C: PRIMER TABLETA SA<br />

TRENUTNIM OSLOBAĐANJEM LEVOTIROKSIN NATRIJUMA<br />

MULTIPLE LEVEL C IN VITRO/IN VIVO CORRELATION OF DISSOLUTION PROFILES:<br />

LEVOTHYROXINE SODIUM IMMEDIATE RELEASE TABLETS CASE STUDY<br />

Ivana Kocić, Irena Homšek, Mirjana Dačević, Branislava Miljković<br />

IKL-8 ICH Q8, Q9 I Q10-IZAZOVI I MOGUĆNOSTI SA ASPEKTA FARMACEUTSKE INDUSTRIJE<br />

GENERIKA<br />

ICH Q8, Q9 AND Q10 - CHALLENGES AND OPPORTUNITIES FROM A GENERIC<br />

PHARMACEUTICAL INDUSTRY POINT OF VIEW<br />

Ljuba Karanakov, Jasmina Tonic-Ribarska, Suzana Trajkovic-Jolevska<br />

IKL-9 ISTOVREMENO ODREĐIVANJE KARBAMAZEPINA I KARBAMAZEPIN-10,11-EPOKSIDA<br />

U HUMANOJ PLAZMI HPLC METODOM<br />

SIMULTANEOUS DETERMINATION OF CARBAMAZEPINE AND CARBAMAZEPINE-10,<br />

11-EPOXIDE IN HUMAN PLASMA BY HPLC METHOD<br />

Jasmina Tonic-Ribarska, Zoran Ster<strong>je</strong>v, Ljubica Šuturkova, Suzana<br />

Trajkovic-Jolevska<br />

IKL-10 ISPITIVANJE DEGRADACIJE API TOKOM PRELIMINARNE STUDIJE STABILNOSTI<br />

INVESTIGATION OF API DEGRADATION IN DRUG PRODUCT PRELIMINARY<br />

STABILITY STUDY<br />

Violeta Dolovac<br />

®<br />

IKL-11 PRAĆENJE STABILNOSTI SPALMOTIL ORALNOG RASTVORA U PREDLOŽENOM<br />

ROKU TRAJANJA<br />

STABILITY TESTING OF SPALMOTIL® ORAL SOLUTION THROUGH THE PROPOSED<br />

SHELF-LIFE PERIOD<br />

Biljana Stojanović, Jelena Veljković, Stojanka Vidović, Mirjana Rajić,<br />

Ljiljana Petrović, Marija Milovanović<br />

IKL-12 PRIMENA VISOKOEFIKASNE TEČNE HROMATOGRAFIJE U ANALIZI PROKAIN<br />

BENZILPENICILINA, BENZATIN BENZILPENICILINA, DIHIDROSTREPTOMICIN SULFATA<br />

I PROKAIN HIDROHLORIDA U FARMACEUTSKIM RASTVORIMA<br />

HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ANALYSIS OF BENZYLPENICILINE,<br />

BENZATHYN BENZYLPENICILLINE, DIHYDROSTREPTOMYCIN SULPHATE, PROCAINE<br />

HYDROCHLORIDE IN PHARMACEUTICAL SOLUTION<br />

Snežana Đorđević, Vesna Kilibarda, Milica Zlatković, Sonja Ćosić, Ljiljana Lupšić<br />

IKL-13 POSTAVLJANJE SPECIFIKACIJE DEGRADACIONIH PROIZVODA: ASPEKTI I SMERNICE<br />

SETTING DEGRADATION PRODUCTS SPECIFICATION: ASPECTS AND GUIDELINES<br />

Slobodanka Cvetićanin, Dragana Kostić, Dejan Mijalković, Nataša Đorđević<br />

Filijović, Nada Marinković

IKL-14 ODREĐIVANJE LIZINOPRILA U FARMACEUTSKIM OBLICIMA PRIMENOM KINETIČKE<br />

METODE<br />

DETERMINATION OF LISINOPRIL IN PHARMACEUTICALS BY A KINETIC METHOD<br />

Mira Čakar, Gordana Popović<br />

IKL-15 RAZDVAJANJE I MIGRACIONO PONAŠANJE ANTIHIPERTENZIVA SA CENTRALNIM<br />

DEJSTVOM I DIURETIKA METODOM KAPILARNE ELEKTROFOREZE UZ PRIMENU<br />

CIKLODEKSTRINA<br />

SEPARATION AND MIGRATION BEHAVIOR OF SOME CENTRALLY ACTING<br />

ANTIHYPERTENSIVES AND DIURETICS BY CYCLODEXTRIN-MEDIATED CAPILLARY<br />

ELECTROPHORESIS<br />

Slavica Filipić, Katarina Nikolić, Irena Vovk, Mitja Križman, Danica Agbaba<br />

IKL-16 RP-HPLC METODA ZA ODREĐIVANJE SADRŽAJA BISOPROLOLA I NJEGOVIH SRODNIH<br />

SUPSTANCI U BISOPROLOL® 5MG TABLETAMA<br />

RP-HPLC METHOD FOR DETERMINATION OF BISOPROLOL AND ITS IMPURITIES IN<br />

BISOPROLOL® 5 MG DOSAGE FORM<br />

Milkica Crevar Sakač, Vedrana Savić, Janko Ignjatović, Zorica Vujić<br />

IKL-17 QSAR PREDVIĐANJE HEPATIČKOG I UKUPNOG KLIRENSA LEKOVA<br />

QSAR PREDICTION OF HEPATIC MICROSOMAL INTRINSIC CLEARANCE AND HUMAN<br />

CLEARANCE VALUES FOR DRUGS<br />

Katarina Nikolić, Slavica Filipić, Danica Agbaba<br />

IKL-18 UTICAJ MEDIJA NA FLUORESCENCIJU EUROPIJUM (III) OKSITETRACIKLIN KOMPLEKSA<br />

MEDIUM EFFECTS ON FLUORESCENCE OF EU (III)-OXYTETRACYCLINE CHELATE<br />

Ervina Bečić, Miroslav Šober, Belma Imamović, Elma Makarević, Mirza Dedić,<br />

Amra Hrvat<br />

IKL-19 LISTA ZA OBELEŽAVANJE SPOLJNJEG I UNUTRAŠNJEG PAKOVANJA LEKA ZA HUMANU<br />

UPOTREBU<br />

INFORMATION LIST FOR OUTER AND IMMEDIATE PACKAGING OF MEDICINAL<br />

PRODUCT FOR HUMAN USE (LABELLING LIST)<br />

Sofija Vrcelj-Jovanović, Ljiljana Vojvodić, Boris Bojić<br />

IKL-20 RAZVOJ I OPTIMIZACIJA RP-HPLC METODE ZA ODREĐIVANJE ZOLPIDEM-TARTARATA<br />

I NJEGOVIH DEGRADACIONIH PROIZVODA U TABLETAMA<br />

DEVELOPMENT AND OPTIMIZATION OF RP-HPLC METHOD FOR SIMULTANEOUS<br />

DETERMINATION OF ZOLPIDEM TARTRATE AND ITS DEGRADATION PRODUCTS IN<br />

TABLETS<br />

Marija Malešević, Ljiljana Živanović, Žarko Jović<br />

IKL-21 TEST ISPITIVANJE BRZINE OSLOBAĐANJA LEKOVITE SUPSTANCE<br />

DISSOLUTION TEST<br />

Gordana Petrović, Marija Pavlović<br />

IKL-22 ISPITIVANJA I ZAHTEVI U SPECIFIKACIJI AKTIVNE SUPSTANCE I GOTOVOG<br />

PROIZVODA<br />

SPECIFICATION TESTS AND ACCEPTANCE CRITERIA FOR ACTIVE SUBSTANCE AND<br />

DRUG PRODUCT<br />

Mirjana Jovanović, Sofija Vrcelj-Jovanović, LjiljanaVojvodić

IKL-23 DEGRADACIONI PROIZVODI U LEKU: INTERAKCIJE SA EKSCIPIJENSIMA<br />

DEGRADATION PRODUCTS:INTERACTIONS WITH EXCIPIENTS<br />

Sofija Vrcelj-Jovanović, Ljiljana Vojvodić, Mirjana Jovanović<br />

IKL-24 PRIMENA BENČMARKING METODOLOGIJE U UNAPREĐENJU REGULATORNE<br />

PERFORMANSE AGENCIJE ZA LEKOVE I MEDICINSKA SREDSTVA SRBIJE<br />

BENCHMARKING METHODOLOGY AS A TOOL IN MEDICINES AND MEDICAL DEVICES<br />

AGENCY OF SERBIA REGULATORY PERFORMANCE IMPROVEMENT<br />

Gordana Pejović<br />

IKL-25 UTICAJ PREMAZIVANJA PLOČA KASKADNOG IMPAKTORA NA AERODINAMIČKU<br />

DISTRIBUCIJU VELIČINE ČESTICA<br />

INFLUENCE OF PLATE COATING ON AERODYNAMIC ASSESSMENT OF FINE PARTICLES<br />

Amar Elezović, Amela Saračević, Alija Uzunović, Saša Pilipović, Šeherzada<br />

Hadžidedić, Alisa Elezović<br />

IKL-26 HEMIJSKI RAZVOJ NOVE AKTIVNE SUPSTANCE: POTENCIJALNE NEČISTOĆE<br />

DEVELOPMENT OF NEW ACTIVE SUBSTANCE: POTENTIAL IMPURITIES<br />

Ljiljana Vojvodić, Mirjana Jovanović, Sofija Vrcelj-Jovanović<br />

IKL-27 ISPITIVANJE STABILNOSTI I KINETIKA RAZGRADNJE PRAMIPEKSOLA PRIMENOM<br />

TEČNE HROMATOGRAFIJE<br />

INVESTIGATION OF PRAMIPEXOLE STABILITY AND DEGRADATION KINETICS USING<br />

LIQUID CHROMATOGRAPHY<br />

Nađa Kostić, Anđelija Malenović, Biljana Jančić-Stojanović<br />

IKL-28 EVALUACIJA METODE TEČNE HROMATOGRAFIJE ZA ANALIZU ROPINIROLA I<br />

NJEGOVE NEČISTOĆE NASTALE OKSIDACIJOM<br />

EVALUATION OF LIQUID CHROMATOGRAPHIC METHOD FOR ANALYSIS OF<br />

ROPINIROL AND ITS IMPURITY ARISING FROM OXIDATION<br />

Tijana Rakić, Anđelija Malenović, Biljana Jančić-Stojanović<br />

IKL-29 VALIDACIJA METODE TEČNE HROMATOGRAFIJE ZA ANALIZU PRAMIPEKSOLA I<br />

NJEGOVIH NEČISTOĆA<br />

VALIDATION OF LIQUID CHROMATOGRAPHIC METHOD FOR THE ANALYSIS OF<br />

PARMIPEXOLE AND ITS IMPURITIES<br />

Ana Vemić, Anđelija Malenović, Biljana Jančić-Stojanović<br />

IKL-30 RAZVOJ I OPTIMIZACIJA RP–HPLC METODE ZA ODREĐIVANJE TORASEMIDA I<br />

NJEGOVIH NEČISTOĆA U TABLETAMA<br />

DEVELOPMENT AND OPTIMIZATION OF RP–HPLC METHOD FOR SIMULTANEOUS<br />

DETERMINATION OF TORASEMIDE AND ITS IMPURITIES IN TABLETS<br />

Žarko Jović, Ljiljana Živanović, Marija Malešević, Ana Protić<br />

IKL-31 VAZODILATATORNI EFEKTI NOVOSINTETISANIH DERIVATA PROPAFENONA<br />

THE VASODILATATION EFFECTS OF NOVEL PROPAFENONE ANALOGS<br />

Branka Ivković, Ljiljana Gojković Bukarica, Bojan Marković, Sote Vladimirov

IKL-32 ANALITIČKA POTVRDA ZLOUPOTREBE EFEDRINA KOD SPORTISTE PRIMENOM<br />

METODE TEČNE HROMATOGRAFIJE SA MS I DIODE ARRAY DETEKCIJOM: PRIKAZ<br />

SLUČAJA<br />

ANALYTICAL CONFIRMATION OF THE ABUSE OF EPHEDRINE IN ATHLETES USING<br />

THE METHOD OF LIQUID CHROMATOGRAPHY WITH PDA AND MS DETECTION: CASE<br />

REPORTS<br />

Gordana Brajković, Dragana Rančić, Olivera Potrebić, Vesna Kilibarda, Snežana<br />

Đorđević, Milica Zlatković<br />

IKL-33 ODREĐIVANJE ROKSITROMICINA U URINU TEČNOM HROMATOGRAFIJOM SA UV<br />

SKENIRAJUĆIM DETEKTOROM<br />

DETERMINATION OF ROXITHROMYCIN IN HUMAN URINE BY LIQUID<br />

CHROMATOGRAPHY WITH PHOTO DIODE ARRAY DETECTION<br />

Snežana Đorđević, Branko Jovanović, Katica Drl<strong>je</strong>vić, Sonja Ćosić, Nadežda Krstić<br />

IKL-34 MULTIKRITERIJUMSKI PRISTUP OPTIMIZACIJI HROMATOGRAFSKE METODE ZA<br />

PRAĆENJE STABILNOSTI MIKOFENOLAT MOFETILA<br />

MULTICRITERIA OPTIMIZATION APPROACH IN DEVELOPMENT OF STABILITY-<br />

INDICATING CHROMATOGRAPHIC METHOD FOR THE ANALYSIS OF MYCOPHENOLATE<br />

MOFETIL<br />

Ana Protić, Ljiljana Živanović, Mira Zečević, Biljana Otašević<br />

IKL-35 VALIDACIJA SPE-HPLC-UV METODE ZA ANALIZU KARBAMAZEPINA I NJEGOVA DVA<br />

METABOLITA, KARBAMAZEPIN EPOKSIDA I KARBAMAZEPIN TRANS-DIOLA, U PLAZMI<br />

PACIJENATA OBOLELIH OD EPILEPSIJE<br />

VALIDATION OF SPE-HPLC-UV METHOD FOR ANALYSIS OF CARBAMAZEPINE AND ITS<br />

TWO METABOLITES, CARBAMAZEPINE EPOXIDE AND CARBAMAZEPINE TRANS-DIOL<br />

IN PLASMA OF EPILEPTIC PATIENTS<br />

Predrag Džodić, Ljiljana Živanović, Ana Protić, Ivana Ivanović, Radmila<br />

Veličković-Radovanović<br />

IKL-36 STUDIJE FORSIRANE DEGRADACIJE<br />

FORCED DEGRADATION STUDIES<br />

Marija Pavlović, Ljiljana Vojvodić, Danica Agbaba<br />

IKL-37 RP HPLC ODREĐIVANJE KISELINSKIH KONSTANTI BETA-HIDROKSI-BETA-<br />

ARILALKANSKIH KISELINA KAO POTENCIJALNIH ANTIINFLAMATORNIH AGENASA<br />

RP-HPLC DETERMINATION OF DISSOCIATION CONSTANTS OF SOME NOVEL<br />

BETA-HYDROXY-BETA-ARYLALKANOIC ACIDS AS POTENTIAL ANTI-INFLAMMATORY<br />

AGENTS<br />

Jelena Savić, Nikolina Kljajić, Sanda Dilber, Sote Vladimirov, Ivan Juranić,<br />

Jasmina Brborić<br />

IKL-38 ODREĐIVANJE KISELINSKIH KONSTANTI PIRIDIN - DIKARBONSKIH KISELINA<br />

DETERMINATION OF THE ACIDITY CONSTANTS OF PYRIDINE DICARBOXYLIC ACID<br />

Branka Dražić, Gordana Popović, Sanja Grgurić-Šipka, Živoslav Tešić,<br />

Ivanka Ivanović

IKL-39 RACIONALNO DIZAJNIRANJE LEKOVA<br />

RATIONAL DRUG DESIGN<br />

Zorica Vujić, Mira Zečević, Milkica Crevar<br />

IKL-40 ISPITIVANJE USLOVA ZA RP-HPLC ANALIZU MOKSONIDINA U PRISUSTVU NJEGOVIH<br />

NEČISTOĆA<br />

INVESTIGATION OF CONDITIONS FOR RP-HPLC ANALYSIS OF MOXONIDINE IN<br />

PRESENTS OF IT`S IMPURITIES<br />

Svetlana Milovanović, Mira Zečević, Biljana Otašević<br />

IKL-41 RAZUMEVANJE UPOTREBE ANTIEPILEPTIČKIH LEKOVA U DEPRESIJI<br />

UNDERSTANDING THE USE OF ANTIEPILEPTIC DRUGS IN DEPRESSION<br />

Snežana Agatonović-Kuštrin, David Morton<br />

IKL-42 KOEFICIJENT DEZINFEKCIONE AKTIVNOSTI RASTVORA ZA ANALIZU BAKTERICIDNE<br />

AKTIVNOSTI RAZLIČITIH RASTVORA ZA DEZINFEKCIJU<br />

DISINFECTION ACTIVITY COEFFICIENT OF SOLUTION IN STUDYING BACTERICIDAL<br />

ACTIVITIES ON DIFFERENT DISINFECTANT SOLUTIONS<br />

Biljana Gjorg<strong>je</strong>ska<br />

IKL-43 EKSPERIMENTALNO PRAĆENJE KONDENZACIJE KETOPROFENA RASTVORENOG U<br />

ACETONITRILU<br />

EXPERIMENTAL EVIDENCE OF A SPONTANEOUS CONDENSATION OF KETOPROFEN<br />

DISSOLVED IN ACETONITRILE<br />

Mieczyslaw Sa<strong>je</strong>wicz, Marcin. Leda, Monika Gontarska, Dorota Kronenbach,<br />

Etienne Berry, Irving.R. Epstein, Teresa Kowalska<br />

IKL-44 EKSPERIMENTALNO PRAĆENJE SPONTANE KONDENZACIJE MLEČNE KISELINE<br />

RASTVORENE U ETANOLU I ACETONITRILU<br />

EXPERIMENTAL EVIDENCE OF A SPONTANEOUS CONDENSATION OF LACTIC ACID<br />

DISSOLVED IN AQUEOUS ETHANOL AND ACETONITRILE<br />

Mieczyslaw Sa<strong>je</strong>wicz, Marcin Leda, Dorota Kronenbach, Monika Gontarska,<br />

Etienne Berry, Irving R. Epstein, Teresa Kowalska<br />

IKL-45 EKSPERIMENTALNO PRAĆENJE SPONTANE KONDENZACIJE FENILGLICINA I<br />

BADEMOVE KISELINE U VODENOM RASTVORU<br />

EXPERIMENTAL EVIDENCE OF A SPONTANEOUS CONDENSATION OF PHENYLGLYCINE<br />

AND MANDELIC ACID IN ABIOTIC AQUEOUS MEDIA<br />

Mieczyslaw Sa<strong>je</strong>wicz, Marcin Leda, Monika Gontarska, Dorota Kronenbach,<br />

Etienne Berry, Irving R. Epstein, Teresa Kowalska<br />

IKL-46 DEKONVOLUCIJA KOMPLEKSA TG-DTG-PODATAKA:PRIMENA U FARMACEUTSKIM<br />

SISTEMIMA<br />

DECONVOLUTION OF COMPLEX TG-DTG DATA: APPLICATIONS IN PHARMACEUTICAL<br />

SYSTEMS<br />

Samuel K. Owusu-Ware, Babur Z. Chowdhry, Stephen A. Leharne,<br />

Milan D. Antoni<strong>je</strong>vić

SEKCIJA ZA FARMAKOEKONOMIJU (FE)<br />

PHARMACOECONOMICS SECTION (FE)<br />

FE-1 DIREKTNI MEDICINSKI TROŠKOVI PROFILAKTIČKE PRIMENE CEFUROKSIMA I<br />

CEFTRIAKSONA KOD ELEKTIVNIH HIRURŠKIH INTERVENCIJA<br />

THE DIRECT MEDICAL COST OF PROPHYLACTIC USE OF CEFUROXIME VERSUS<br />

CEFTRIAXONE IN ELECTIVE SURGICAL INTERVENTION<br />

Dragana Lakić, Milena Radmilović, Katarina Ilić, Ljiljana Tasić, Marija<br />

Milenković, Ivana Tadić, Marina Petrić<br />

FE-2 KOMPARATIVNA ANALIZA POTROŠNJE INSULINA U OPŠTINI BITOLA TOKOM<br />

2007/2008. GODINE<br />

COMPARATIVE ANALYSIS OF THE CONSUMPTION OF INSULINS IN BITOLA DURING<br />

Slavica Jurukovska, Elena Jurukovska, Čedomir Dimitrovski<br />

FE-3 ABC ANALIZA TROŠKOVA ZA LEKOVE U DOMU ZDRAVLJA NOVI SAD<br />

ABC ANALYSIS OF DRUG EXPENDITURE IN HEALTH CENTER NOVI SAD<br />

Božana Nikolić, Ana Pilipović, Mladena Lalić<br />

FE-4 TRENDOVI UPOTREBE LEKOVA - INJEKCIJA U DOMU ZDRAVLJA NOVI SAD<br />

TRENDS IN USAGE OF INJECTION DRUGS IN HEALTH CENTER NOVI SAD<br />

Božana Nikolić, Ana Pilipović, Mladen Lalić<br />

FE-5 ESENCIJALNA LISTA LIJEKOVA-OSNOV ZA FARMAKOPOLITIKU<br />

LIST OF ESSENTIAL MEDICINES – BASIS FOR PHARMACY POLICY<br />

Armin Škrbo, Ana Pantović<br />

FE-6 ANALYSIS OF OUTPATIENT CONSUMPTION OF ORAL ANTIDIABETICS IN THE<br />

REPUBLIC OF SRPSKA, BOSNIA AND HERZEGOVINA<br />

Valentina Topić, Nebojša Mihajlica<br />

FE-7 NARODNO LIJEČENJE KROZ HISTORIJU - KAO DIO FARMACIJE<br />

HISTORICAL FOLK'S CURE AS PART OF THE PHARMACY<br />

Armin Škrbo, Maida Piralić, Mijat Tuka<br />

FE-8 RETAIL PHARMACY SERVICES - BRANDING SERVICES<br />

Svetlana Neceva, Rubin Zarevski<br />

FE-9 WHO GOOD GOVERNANCE FOR MEDICINES PROGRAMME: MACEDONIAN<br />

EXPIRIENCES<br />

Renata Slaveska Raichki, Arta Kuli, Mihail Minov<br />

FE-10 EVALUACIJA POTROŠNJE ANTIHIPERTENZIVA U REPUBLICI SRBIJI U PERIODU<br />

OD 2004-2008<br />

EVALUATION OF ANTIHYPERTENSIVES CONSUMPTION IN THE REPUBLIC OF<br />

SERBIA FROM 2004-2008<br />

Katarina Ilić, Danka Stefanović, Vesela Radonjić

SEKCIJA ZA FARMACEUTSKU ZDRAVSTVENU ZAŠTITU – BOLNIČKA<br />

FARMACIJA (FZZ-BOL)<br />

PHARMACEUTICAL CARE – HOSPITAL PHARMACY SECTION (FZZ – BOL)<br />

FZZ-BOL-1 ANALIZA BOLNIČKE POTROŠNJE LEKOVA ZA LEČENJE OSTEOPOROZE<br />

ANALYSIS OF HOSPITAL CONSUMPTION OF DRUGS IN TREATING OSTEOPOROSIS<br />

Aleksandra Kovačević, Aneta Perić, Maja Bojović<br />

FZZ-BOL-2 ANALIZA BOLNIČKE POTROŠNJE ACE INHIBITORA I ANTAGONISTA RECEPTORA<br />

ANGIOTENZINA II<br />

ANALYSIS OF HOSPITAL CONSUMPTION OF ANGIOTENSIN-CONVERTING<br />

ENZYME INHIBITORS AND ANGIOTENSIN II RECEPTOR ANTAGONISTS<br />

Aneta Perić, Maja Bojović<br />

FZZ-BOL-3 PROCENA UTICAJA KOMBINOVANE TERAPIJE VALPROINSKOM KISELINOM ILI<br />

KARBAMAZEPINOM NA METABOLIZAM I FARMAKOKINETIKU MOKLOBEMIDA KOD<br />

DEPRESIVINIH BOLESNIKA<br />

THE EFFECTS OF COMBINATION THERAPY WITH VALPROIC ACID OR<br />

CARBAMAZEPINE ON MOCLOBEMIDE METABOLISM AND PHARMACOKINETICS IN<br />

DEPRESSIVE PATIENTS<br />

Anita Rakić Ignjatović, Branislava Miljković, Dejan Todorović, Ivana Timoti<strong>je</strong>vić,<br />

Milena Pokrajac<br />

FZZ-BOL-4 PREDVIĐANJE KONCENTRACIJA SIROLIMUSA U PACIJENATA SA TRANSPLANTIRANIM<br />

BUBREGOM PRIMENOM VEŠTAČKIH NEURONSKIH MREŽA<br />

PREDICTION OF SIROLIMUS CONCENTRATIONS IN KIDNEY TRANSPLANT PATIENTS<br />

BY USING ARTIFICIAL NEURAL NETWORKS<br />

Bojana Perović, Jelena Petrović, Radmila Blago<strong>je</strong>vić-Lazić, Dragana<br />

Radivo<strong>je</strong>vić-Đokić, Milica Prostran, Branislava Miljković<br />

FZZ-BOL-5 FARMACEUTSKI OBLICI U TERAPIJI KARDIOVASKULARNIH OBOLJENJA: ASPEKTI<br />

AKTIVNOSTI KLINIČKOG FARMACEUTA<br />

DOSAGE FORMS OF CARDIOVASCULAR DRUGS: THE ASPECT OF THE ACTIVITIES<br />

OF CLINICAL PHARMACISTS<br />

Branka Brzaković, Gordana Vuleta, Branislava Miljković<br />

FZZ-BOL-6 IZRADA UPUTSTVA ZA PRIPREMU I PRIMENU ANTIBIOTIKA<br />

PREPARING INSTRUCTIONS FOR THE PREPARATION AND USE OF ANTIBIOTICS<br />

Dijana Ribar<br />

FZZ-BOL-7 ANTIBIOTICS POLICY AS A TOOL FOR OPTIMIZING THE HOSPITAL MEDICINES<br />

UTILIZATION<br />

Petrova Guenka, Assena Stoimenova, Manoela Manova, Alexandra Savova,<br />

Elena Arnaudova<br />

FZZ-BOL-8 FARMAKOKINETIKA LIDOKAINA U PACIJENATA SA KARCINOMOM JETRE NAKON<br />

IZVOĐENJA LIDOKAINSKOG TESTA RADI PROCENE FUNKCIJE JETRE<br />

LIDOCAINE PHARMACOKINETICS IN PATIENTS WITH LIVER CARCINOMA AFTER<br />

LIDOCAINE TEST PERFORMANCE FOR LIVER FUNCTION EVALUATION<br />

Ivan Palibrk, Jelena Golubović, Jasna B<strong>je</strong>lanović, Katarina Vučićević

FZZ-BOL-9 EVALUACIJA SPONTANOG PRIJAVLJIVANJA NEŽELJENIH REAKCIJA NA LEKOVE U<br />

BOLNIČKOJ APOTECI U PERIODU JANUAR 2005- JUN 2010<br />

EVALUATION OF ADVERSE DRUG REACTIONS (ADRs) REPORTING IN HOSPITAL<br />

PHARMACY IN THE PERIOD JANUARY 2005-JUNE 2010<br />

Jasminka Dragić<br />

FZZ-BOL-10 NAJČEŠĆI UZROČNICI URINARNIH INFEKCIJA U BOLNIČKIM USLOVIMA<br />

HOSPITAL ACQUIRED URINARY INFECTIONS<br />

Jelena Nikić, Nenad Miljković<br />

FZZ-BOL-11 ANTIKOAGULANTNA KLINIKA VOĐENA OD STRANE FARMACEUTA U SRBIJI<br />

A PHARMACIST–LED ANTICOAGULATION CLINIC IN SERBIA<br />

Milica Ćulafić<br />

FZZ-BOL-12 ULOGA BOLNIČKOG FARMACEUTA U ZDRAVSTVENOM TIMU POLIKLINIKE<br />

25. UNIVERZIJADE - BEOGRAD 2009<br />

ROLE OF HOSPITAL PHARMACIST IN POLYCLINIC HEALTH TEAM ON<br />

TH<br />

25 UNIVERSIADE - BELGRADE 2009<br />

Mirjana Antunović, Jasmina Zečević, Dušica Mirković, Aneta Perić<br />

FZZ-BOL-13 UPOREDNA STUDIJA INFEKCIJA IZAZVANIH MULTIREZISTENTNIM SOJEVIMA<br />

KOAGULAZA NEGATIVNOG STAFILOKOKA<br />

THE COMPARATIVE STUDY OF INFECTIONS CAUSED BY MULTIRESISTANT<br />

COAGULASE-NEGATIVE STAPHYLOCOCCUS<br />

Nenad Miljković, Jelena Nikić<br />

FZZ-BOL-14 LITIJUMOM PROUZROKOVANA ASIMPTOMATSKA HIPERKALEMIJA: PRIKAZ SLUČAJA<br />

A LITHIUM INDUCED ASYMPTOMATIC HYPERKALEMIA: CASE REPORT<br />

Tanja Radović, Aleksandra Todorović<br />

FZZ-BOL-15 IMPLEMENTIRANJE CENTRALIZOVANE JEDINICE ZA PRIPREMU HEMOTERAPIJE U<br />

NAJVEĆU BOLNICU U REPUBLICI SRPSKOJ (BOSNA I HERCEGOVINA)<br />

IMPLEMENTING A CENTRALISED UNIT FOR CHEMOTHERAPY PREPARATION INTO<br />

THE LARGEST HOSPITAL IN THE REPUBLIC OF SRPSKA (BOSNIA AND HERZEGOVINA)<br />

Tijana Marinković

th<br />

Subota, 16. oktobar 2010. / Saturday, October 16 , 2010<br />

09:00-18:00<br />

12:00-13:00<br />

13:00-13:30<br />

Poster prezentaci<strong>je</strong> sekcija LB, FTK i TSH<br />

Poster presentations of sections LB, FTK and TSH<br />

Prisustvo autora<br />

Presence of authors<br />

Diskusija o odabranim poster prezentacijama sekcija LB, FTK i TSH<br />

Discussion on poster presentations of sections LB, FTK and TSH<br />

SEKCIJA ZA LEKOVITO BILJE (LB)<br />

MEDICINAL PLANTS SECTION (LB)<br />

LB-1 ANTIEDEMATOZNA I GASTROPROTEKTIVNA AKTIVNOST ULJANIH EKSTRAKATA<br />

VRSTE HYPERICUM RICHERI<br />

ANTI-EDEMATOUS AND GASTROPROTECTIVE ACTIVITY OF HYPERICUM RICHERI<br />

OIL EXTRACTS<br />

Gordana Zdunić, Dejan Gođevac, Marina Milenković, Katarina Šavikin,<br />

Nebojša Menković, Silvana Petrović<br />

LB-2 ANTIEDEMATOZNA AKTIVNOST ETARSKIH ULJA IZ PODZEMNIH ORGANA<br />

LASERPITIUM ZERNYI HAYEK I CVASTI KAMILICE, MATRICARIA RECUTITA L.<br />

ANTI-EDEMATOUS ACTIVITY OF ESSENTIAL OILS FROM UNDERGROUND PARTS OF<br />

LASERPITIUM ZERNYI HAYEK AND FLOWERS OF MATRICARIA RECUTITA L.<br />

Višnja Popović, Ana Micov, Maja Tomić, Radica Stepanović-Petrović,<br />

Silvana Petrović<br />

LB-3 ISPITIVANJE CITOTOKSIČNE I ANTIOKSIDANTNE AKTIVNOSTI EKSTRAKATA FERULA<br />

HEUFFELII GRISEB. EX HEUFFEL (APIACEAE)<br />

INVESTIGATION OF ANTIOXIDANT AND CYTOTOXIC ACTIVITY OF FERULA HEUFFELII<br />

GRISEB. EX HEUFFEL (APIACEAE) EXTRACTS<br />

Ivan Pavlović, Silvana Petrović, Zorica Juranić, Tatjana Stanojković,<br />

Jelena Kukić-Marković, Marjan Niketić<br />

LB-4 ISPITIVANJE UTICAJA ETANOLNOG I METANOLNOG EKSTRAKTA VRSTE DICTAMNUS<br />

ALBUS NA VIABILNOST I PROLIFERACIJU HELA ĆELIJA<br />

EXAMINATION OF DICTAMNUS ALBUS LEAVES ETHANOL AND METHANOL EXSTRACTS<br />

ON HELA CELLS VIABILITY AND PROLIFERATION<br />

Dragana Pavlović, Marija Vukelić, Jelena Živanov-Čurlis, Dušanka Kitić,<br />

Bojan Zlatković, Stevo Najman<br />

LB-5 ISPITIVANJE ANTIMIKROBNE AKTIVNOSTI EKSTRAKATA HERBE I RIZOMA PREVOLCA,<br />

EPIMEDIUM ALPINUM L. (BERBERIDACEAE)<br />

INVESTIGATION OF ANTIMICROBIAL ACTIVITY OF EPIMEDIUM ALPINUM L.<br />

(BERBERIDACEAE) HERB AND RHIZOME EXTRACT<br />

Zvezdana Došlov-Kokoruš, Marina Milenković, Nada Kovačević

LB-6 ISPITIVANJE ANTIOKSIDANTNOG POTENCIJALA I FENOLNIH SASTOJAKA<br />

ALCHEMILLA VELEBITICA (BORBÁS EX JANCHEN) DEGEN (ROSACEAE)<br />

INVESTIGATION ON ANTIOXIDANT POTENTIAL AND PHENOLIC COMPOUNDS OF<br />

ALCHEMILLA VELEBITICA (BORBÁS EX JANCHEN) DEGEN (ROSACEAE)<br />

Jelena Kukić-Marković, Boško Bondžulić, Silvana Petrović, Marjan Niketić<br />

LB-7 ANTIRADIKALSKA AKTIVNOST ACETONSKOG EKSTRAKTA SANGUISORBA<br />

OFFICINALIS L. (ROSACEAE)<br />

ANTIRADICAL ACTIVITY OF SANGUISORBA OFFICINALIS L. (ROSACEAE) ACETONE<br />

EXTRACT<br />

Jelena Kukić-Marković, Larisa Vujnović, Ivana Najdenov, Goran Janković<br />

LB-8 HEMIJSKI SASTAV I ANTIMIKROBNA AKTIVNOST ETARSKIH ULJA VRSTA LASERPITIUM<br />

LATIFOLIUM L. I LASERPITIUM OCHRIDANUM MICEVSKI (APIACEAE)<br />

CHEMICAL COMPOSITION AND ANTIMICROBIAL ACTIVITY OF ESSENTIAL OILS OF<br />

LASERPITIUM LATIFOLIUM L. AND LASERPITIUM OCHRIDANUM MICEVSKI (APIACEAE)<br />

Višnja Popović, Silvana Petrović, Milica Pavlović-Drobac, Marina Milenković,<br />

Maria Couladis, Marjan Niketić<br />

LB-9 HEMIJSKI SASTAV I ANTIMIKROBNA AKTIVNOST ETARSKOG ULJA ACHILLEA<br />

MULTIFIDA DC. (GRISEB) (COMPOSITAE)<br />

CHEMICAL COMPOSITION AND ANTIMICROBIAL ACTIVITY OF ACHILLEA MULTIFIDA<br />

DC. (GRISEB) (COMPOSITAE) ESSENTIAL OIL<br />

Milica Pavlović-Drobac, Silvana Petrović, Marina Milenković, Olga Tzakou,<br />

Marjan Niketić, Nada Kovačević<br />

LB-10 SADRŽAJ I SASTAV ETARSKOG ULJA SALVIA OFFICINALIS L. (LAMIACEAE) U<br />

ZAVISNOSTI OD LOKALITETA I SEZONSKIH PROMENA<br />

CONTENT AND COMPOSITION OF ESSENTIAL OIL OF SALVIA OFFICINALIS L.<br />

(LAMIACEAE) DEPENDING ON LOCATION AND SEASONAL VARIATIONS<br />

Violeta Slavkovska, Mihailo Ristić, Branislava Lakušić, Dmitar Lakušić<br />

LB-11 HEMIJSKI SASTAV ETARSKOG ULJA PLODA HERACLEUM PYRENAICUM LAM. SUBSP.<br />

POLLINIANUM (BERTOL.) PEDROTTI & PIGNATTI<br />

CHEMICAL COMPOSITION OF THE FRUIT ESSENTIAL OIL OF HERACLEUM<br />

PYRENAICUM LAM. SUBSP. POLLINIANUM (BERTOL.) PEDROTTI & PIGNATTI<br />

Milica Pavlović-Drobac, Silvana Petrović, Marjan Niketić<br />

LB-12 HEMIJSKI SASTAV ISPARLJIVIH SUMPORNIH JEDINJENJA SAMONIKLIH PREDSTAVNIKA<br />

SEKCIJE ALLIUM (ALLIUM SP., SECT. ALLIUM)<br />

CHEMICAL COMPOSITION OF VOLATILE SULFUR COMPOUNDS IN WILD GROWING<br />

GARLICS (ALLIUM SP., SECT. ALLIUM)<br />

Biljana Božin, Dejan Orčić, Goran Anačkov, Bojan Zlatković, Nataša Simin,<br />

Neda Mimica-Dukić<br />

LB-13 MASNE KISELINE IZ SEMENA PASTINACA HIRSUTA PANČIĆ (APIACEAE)<br />

SEED FATTY ACID COMPOSITION OF PASTINACA HIRSUTA PANČIĆ (APIACEAE)<br />

Peđa Janaćković, Vele Tešević, Nemanja Rajčević, Zoran Krivošej, Petar Marin

LB-14 ODREĐIVANJE SADRŽAJA CINKA, BAKRA I HROMA U POJEDINIM VERONICA VRSTAMA<br />

(PLANTAGINACEAE) I UZORCIMA ZEMLJIŠTA SA RAZLIČITIH LOKALITETA U SRBIJI<br />

DETERMINATION OF ZN, CU AND CR IN SOME VERONICA SPECIES (PLANTAGINACEAE)<br />

AND SOIL SAMPLES FROM SEVERAL LOCATIONS IN SERBIA<br />

Jelena Živković, Zoran Maksimović, Jelena Arseni<strong>je</strong>vić, Slavica Ražić<br />

LB-15 ISPITIVANJE KVALITETA PROIZVODA SA KAMILICOM<br />

QUALITY STUDY OF PRODUCTS WITH CHAMOMILE<br />

Maja Mitrović, Branislava Lakušić, Nada Kovačević, Tatjana Kundaković<br />

LB-16 PROCENA KVALITETA KOMERCIJALNIH ECHINACEA PROIZVODA U AUSTRALIJI<br />

QUALITY ASSESSMENT OF COMMERCIAL ECHINACEA PRODUCTS IN AUSTRALIA<br />

David Morton, Snežana Agatonović-Kuštrin<br />

LB-17 A COMPARISON OF TRADITIONAL AND ALTERNATIVE<br />

FINGERPRINTING METHODS WITH ESSENTIAL OILS DERIVED FROM PLANT MATERIAL<br />

Mieczysław Sa<strong>je</strong>wicz, Łukasz Wojtal, Maja Natić, Monika Waksmundzka-Hajnos,<br />

Teresa Kowalska<br />

LB-18 A COMPARISON OF TRADITIONAL AND ALTERNATIVE FINGERPRINTING METHODS<br />

WITH PHENOLIC COMPOUNDS DERIVED FROM PLANT MATERIAL<br />

Mieczysław Sa<strong>je</strong>wicz, Dorota Staszek, Łukasz Cieśla, Maja Natić, Monika<br />

Waksmundzka-Hajnos, Teresa Kowalska<br />

LB-19 ISPITIVANJE ANTIINFLAMATORNOG DJELOVANJA MASTI SA SUVIM EKSTRAKTIMA<br />

RIZOMA I HERBE POTENTILLA RECTA L. (ROSACEAE)<br />

INVESTIGATION OF ANTI-INFLAMMATORY ACTIVITY OF OINTMENTS WITH DRY<br />

EXTRACTS OF RHIZOME AND HERB OF POTENTILLA RECTA L. (ROSACEAE)<br />

Saša Pilipović, Nedžad Mulabegović, Zakira Mornjaković, Alija Uzunović,<br />

Amar Elezović, Šeherzada Hadžidedić<br />

LB-20 PRIMENA LEKOVITIH BILJAKA SA NAŠEG PODNEBLJA ZA UBLAŽAVANJE UPALNIH<br />

PROCESA NA KOŽI I SLUZOKOŽI<br />

USE OF MEDICINAL HERBS FROM OUR LOCALITIES FOR REDUCING INFLAMMATION<br />

OF SKIN AND MUCOUS MEMBRANE<br />

Jelena Svatok, Ljubinka Lemajić, Tatjana Kundaković, Nada Kovačević<br />

LB-21 THIN-LAYER CHROMATOGRAPHY FOR FINGERPRINTING AND SCREENING THE<br />

BIOLOGICAL ACTIVITY OF PLANT EXTRACTS<br />

Monika Waksmundzka-Hajnos<br />

LB-22 EFFECT OF IONIC LIQUID ADDITIVES TO MOBILE PHASE ON SEPARATION AND<br />

SYSTEM EFFICIENCY FOR HPLC OF SELECTED ALKALOIDS ON DIFFERENT<br />

STATIONARY PHASES<br />

Anna Petruczynik

SEKCIJA ZA FARMACEUTSKU TEHNOLOGIJU I KOZMETOLOGIJU (FTK)<br />

PHARMACEUTICAL TECHNOLOGY AND COSMETOLOGY SECTION (FTK)<br />

FTK-1 UTICAJ MOLARNOG ODNOSA SURFAKTANT/LEK NA ADSORPCIJU I OSLOBAĐANJE<br />

DIKLOFENAK NATRIJUMA IZ LEK-MODIFIKOVANI ZEOLIT KOMPOZITA<br />

THE INFLUENCE OF SURFACTANT/DRUG MOLAR RATIO ON ADSORPTION AND<br />

RELEASE OF DICLOFENAC SODIUM FROM DRUG-MODIFIED ZEOLITE COMPOSITES<br />

Danina Krajišnik, Jela Milić, Aleksandra Daković, Anđelija Malenović,<br />

Bojan Čalija<br />

FTK-2 IZRADA I PROFILI OSLOBAĐANJA ALGINATNIH MIKROČESTICA OBLOŽENIH<br />

HITOZANOM I ALGINATNIH MIKROČESTICA PRIPREMLJENIH MEŠANJEM SA HPMC<br />

PREPARATION AND RELEASE PROFILES OF CHITOSAN-COATED AND HPMC-BLENDED<br />

ALGINATE MICROPARTICLES<br />

Nebojša Cekić, Jela Milić, Bojan Čalija, Snežana Savić, Miroslav Savić<br />

FTK-3 LIPIDNE NANOČESTICE STABILIZOVANE POLIGLICEROLSKIM ESTRIMA MASNIH<br />

KISELINA: FIZIČKA STABILNOST I OKLUZIVNE OSOBINE<br />

POLYGLYCEROL FATTY ACID ESTER BASED LIPID NANOPARTICLES: PHYSICAL<br />

STABILITY AND OCCLUSIVE PROPERTIES<br />

Anđelka Kovačević, Snežana Savić, Gordana Vuleta, Jela Milić, Cornelia Keck,<br />

Rainer Helmut Müller<br />

FTK-4 FORMULACIJA I ISPITIVANJE STABILNOSTI LIPIDNIH NANOČESTICA SA TAKROLIMUSOM<br />

FORMULATION AND STABILITY INVESTIGATION ON TACROLIMUS - LOADED LIPID<br />

NANOPARTICLES<br />

Anđelka Kovačević, Snežana Savić, Gordana Vuleta, Jela Milić, Cornelia Keck,<br />

Rainer Helmut Müller<br />

FTK-5 FORMULATION AND EVALUATION OF SILICA BASED XEROGEL MICROPARTICLES<br />

FOR COLON DELIVERY OF 5-FU<br />

Beti Djurdjic, Marija Dodov Glavas, Nikola Geskovski, Maja Simonoska Crcarevska,<br />

Vesna Petrovska, Katerina Goracinova<br />

FTK-6 FIZIČKOHEMIJSKA KARAKTERIZACIJA HITOZAN-CA-ALGINATNIH MIKROČESTICA SA<br />

NAPROKSENOM IZRAĐENIH POSTUPKOM JONOTROPNOG GELIRANJA I<br />

POLIELEKTROLITNOG KOMPLEKSIRANJA<br />

PHYSICOCHEMICAL CHARACTERIZATION OF NAPROXEN LOADED<br />

CHITOSAN-CA-ALGINATE MICROPARTICLES PRODUCED BY IONOTROPIC GELATION<br />

AND POLYELECTROLYTE COMPLEXATION<br />

Bojan Čalija, Jela Milić, Nebojša Cekić, Snežana Savić<br />

FTK-7 PHYSICO-CHEMICAL CHARACTERIZATION OF BIODEGRADABLE POLYMERIC<br />

NANOPARTICLES LOADED WITH CPT-11<br />

Maja Simonoska Crcarevska, Marija Glavas Dodov, Sema Calis, Vesna Petrovska,<br />

Jasmina Tonic Ribarska, Katerina Goracinova<br />

FTK-8 CHARACTERIZATION OF BUDESONIDE LOADED GLYCERIDE NANOPARTICLES COATED<br />

WITH NON-IONIC SURFACTANT<br />

Hristina Litovin, Katerina Goracinova, Maja S. Crcarevska, Nikola Geskovski,<br />

Sanja Ostojic, Marija D. Glavas

FTK-9 CITOZAN-CALCIUM-ALGINATNE MIKROCESTICE SA L. CASEI; VITALNOST ZA VREME<br />

MIKROINKAPSULIRANJA I U SIMULIRANIM IN VIVO USLOVIMA<br />

VIABILITY OF L. CASEI DURING MICROENCAPSULATION IN<br />

CHITOSAN-CALCIUM-ALGINATE MICROPARTICLES AND IN SIMULATED IN VIVO<br />

CONDITIONS<br />

Tanja Petreska Ivanovska, Margita Dabevska-Kostoska, Nikola Geskovski,<br />

K. Smilkov, Emil Popovski, Lidija Petrusevska-Tozi, Kristina Mladenovska<br />

FTK-10 NANOČESTICE NA BAZI UGLJENIKA-NOVI NOSAČI LEKOVA?<br />

CARBON NANOPARTICLES-NOVEL DRUG CARRIERS?<br />

Mirjana Đukić, Vesna Milovanović, Aleksandra Buha, Evica Antoni<strong>je</strong>vić,<br />

Ivana Stevanović, Milica Ninković<br />

FTK-11 UTICAJ PRIMARNE AMBALAŽE NA FOTOSTABILNOST KARVILEKS TABLETA<br />

INFLUENCE OF PRIMARY PACKAGING ON PHOTOSTABILITY OF KARVILEKS TABLETS<br />

Valentina Marinković, Ivan Savić, Predrag Sibinović, Miroslav Milenković,<br />

Ivana Savić<br />

FTK-12 MANUFACTURING PROCESS OPTIMIZATION OF ZOLPIDEM TABLETS<br />

Packa Antovska, Bosilka Stefanova, Filip Butikoski, Blagica Debarlieva,<br />

Sonja Ugarkovic<br />

FTK-13 RAZVOJ FORMULACIJE I EVALUACIJA AMLODIPIN BESILAT TABLETA<br />

FORMULATION AND EVALUATION OF AMLODIPINE BESYLATE TABLETS<br />

Berina Pilipović, Midhat Vehabović, Ervina Hadžović, Selma Šehić, Vlado Mekinjić<br />

FTK-14 IN VITRO I IN VIVO EVALUACIJA TRAMADOL KAPSULA<br />

IN VITRO AND IN VIVO EVALUATION OF TRAMADOL CAPSULES<br />

Midhat Vehabović, Berina Pilipović, Nermina Tvrtković, Aydın Erenmemisoglu,<br />

Wolfgang Martin, Ilker Kanzik<br />

FTK-15 UTICAJ USLOVA SUŠENJA RASPRŠIVANJEM NA KARAKTERISTIKE PRAŠKOVA ISPITIVAN<br />

PRIMENOM EKSPERIMENTALNOG DIZAJNA<br />

INFLUENCE OF SPRAY DRYING CONDITIONS ON POWDER CHARACTERISTICS<br />

EXAMINED BY EXPERIMENTAL DESIGN<br />

Tijana Mihajlović, Aleksandar Mladenović, Svetlana Ibrić<br />

FTK-16 GRANULACIJA TOPLJENJEM U UREĐAJU TIPA FLUIDIZIRAJUĆEG SISTEMA – METODA<br />

ZA MASKIRANJE GORKOG UKUSA PARACETAMOLA<br />

FLUIDIZED HOT MELT GRANULATION – APPROACH TO MASK THE BITTER TASTE OF<br />

PARACETAMOL<br />

Ivana Mašić, Aleksandra Stojković, Jelena Parojčić, Zorica Đurić<br />

FTK-17 POREĐENJE METODA ZA ISPITIVANJE BRZINE RASTVARANJA GRANULA I TABLETA<br />

SA MODIFIKOVANIM OSLOBAĐANJEM PARACETAMOLA<br />

COMPARATIVE DISSOLUTION TESTING OF PARACETAMOL EXTENDED RELEASE<br />

GRANULES AND TABLETS USING DIFFERENT DISSOLUTION TEST APPARATUSES<br />

Aleksandra Stojković, Ivana Mašić, Jelena Parojčić, Zorica Đurić

FTK-18 UTICAJ TIPA LAKTOZE NA KARAKTERISTIKE TABLETA SA TRENUTNIM<br />

OSLOBAĐANJEM KOJE SADRŽE ATIPIČNE ANTIPSIHOTIKE<br />

AN INVESTIGATION INTO THE INFLUENCE OF THE TYPE OF LACTOSE ON THE<br />

CARACTERISTICS OF IMMEDIATE-RELEASE TABLETS CONTAINING ATYPICAL<br />

ANTIPSYCHOTICS<br />

Marija Đokić, Jovana Božić, Aleksandar Pavlović<br />

FTK-19 FUNKCIONALNOST EKSCIPIJENASA I ODGOVARAJUĆI REGULATORNI ZAHTEVI<br />

FUNCTIONALITY RELATED CHARACTERISTICS OF PHARMACEUTICAL EXCIPIENTS<br />

AND RELEVANT REGULATORY REQUIREMENTS<br />

Stana Ubavić<br />

FTK-20 IN SILICO PREDVIĐANJE RESORPCIJE NIMESULIDA IZ TABLETA SA TRENUTNIM<br />

OSLOBAĐANJEM<br />

MECHANISTIC SIMULATION OF NIMESULIDE ABSORPTION FROM IR TABLETS<br />

Sandra Grbić, Jelena Parojčić, Zorica Đurić<br />

FTK-21 KOMPARATIVNA IN VITRO/IN VIVO KARAKTERIZACIJA EMULZIONIH PODLOGA SA<br />

ALKIL POLIGLUKOZIDNIM EMULGATOROM KAO NOSAČA ZA DIKLOFENAK I<br />

KETOPROFEN<br />

COMPARATIVE IN VITRO/IN VIVO ASSESSMENT OF EMULSION VEHICLES BASED ON<br />

ALKYL POLYGLUCOSIDE EMULSIFIER AS DELIVERY SYSTEMS FOR DICLOFENAC AND<br />

KETOPROFEN<br />

Ivana Jakšić, Milica Lukić, Jela Milić, Rolf Daniels, Snežana Savić<br />

FTK-22 KARAKTERIZACIJA U/V KREMOVA STABILIZOVANIH “PRIRODNIM” EMULGATOROM<br />

POLIGLICERIL-3 METILGLUKOZA DISTEARAT<br />

CHARACTERIZATION OF O/W CREAMS STABILIZED WITH NATURAL EMULSIFIER<br />

POLYGLYCERYL-3 METHYLGLUCOSE DISTEARATE<br />

Marija Golubović, Danina Krajišnik, Dragana Vasil<strong>je</strong>vić<br />

FTK-23 IN VITRO I IN VIVO PROCENA EMULZIJA SA SRUKTUROM TEČNIH KRISTALA KAO<br />

NOSAČA ZA DIKLOFENAK DIETILAMIN<br />

IN VITRO AND IN VIVO EVALUATION OF EMULSIONS WITH LAMELLAR LIQUID<br />

CRYSTALLINE STRUCTURE AS VEHICLES FOR DICLOFENAC DIETHYLAMINE<br />

Nada Vučinić Milanković, Snežana Savić, Gordana Vuleta, Slavica Vučinić<br />

FTK-24 FORMULISANJE V/U EMULZIJE ZA NEGU SUVE KOŽE: OPTIMALNE REOLOŠKE I<br />

SENZORIJELNE KARAKTERISTIKE<br />

FORMULATING OF W/O EMULSION FOR DRY SKIN: OPTIMAL RHEOLOGICAL AND<br />

SENSORY CHARACTERISTICS<br />

Milica Lukić, Ivana Jakšić, Gordana Vuleta, Snežana Savić<br />

FTK-25 FORMULACIJA I KARAKTERIZACIJA U/V KREMOVA ZA POSVETLJIVANJE<br />

HIPERPIGMENTACIJA KOŽE IZRAĐENIH SA NATRIJUM-ASKORBILFOSFATOM<br />

FORMULATION AND CHARACTERISATION OF O/W CREAMS CONTAINING SODIUM<br />

ASCORBYL PHOSPHATE AS SKIN HIPERPIGMENTATION LIGHTENING INGREDIENT<br />

Marijana Milosavl<strong>je</strong>vić, Dragana Vasil<strong>je</strong>vić, Marija Primorac

FTK-26 ZNAČAJ UPOTREBE ANTIOKSIDANASA U KOZMETIČKIM PROIZVODIMA NAMENJENIM<br />

ZA ZAŠTITU KOŽE OD UV ZRAČENJA<br />

THE IMPORTANCE OF ANTIOXIDANTS USAGE IN COSMETIC PRODUCTS DESIGNED<br />

FOR UV SKIN PROTECTION<br />

Bojana Vučelić, Nataša Živanović, Mirjana Tasić<br />

FTK-27 ALKILPOLIGLUKOZIDNI VS. TRADICIONALNI POLIETILENGLIKOLNI EMULGATORI KAO<br />

STABILIZATORI EMULZIJA - FIZIČKOHEMIJSKA KARAKTERIZACIJA I INVITRO/IN VIVO<br />

ISPITIVANJE EFEKATA NA KOŽI<br />

ALKYLPOLYGLUCOSIDE VS. TRADITIONAL POLYETHYLENE GLYCOL EMULSIFIER-<br />

BASED EMULSIONS - PHYSICOCHEMICAL AND IN VITRO/IN VIVO SKIN PERFORMANCE<br />

INVESTIGATION<br />

Marija Tasić-Kostov, Milica Lukić, Gordana Vuleta, Snežana Savić<br />

FTK-28 ISPITIVANJE ANTIIRITANTNOG I VLAŽEĆEG EFEKTA KREMA SA BILJNIM<br />

EKSTRAKTIMA NA VEŠTAČKI IRITIRANU KOŽU<br />

EVALUATION OF ANTIIRRITATING AND MOISTURIZING EFFECTS OF THE CREAM<br />

CONTAINING SELECTED HERB EXTRACTS ON SURFACTANT-IRRITATED SKIN<br />

Ivana Arsić, Vanja Tadić, Marija Tasić-Kostov, Vesna Savić, Nataša Blažević-<br />

Kamenov, Sofija Đorđević, Dušanka Runjaić-Antić<br />

FTK-29 UTICAJ SADRŽAJA POLIETILENGLIKOLA 400 NA PERMEACIJU FLUKONAZOLA IZ<br />

FORMULACIJA LAKA ZA NOKTE KROZ MEMBRANU GOVEĐEG PAPKA<br />

INFLUENCE OF POLYETHYLENE GLYCOL 400 CONTENT ON PERMEATION OF<br />

FLUCONAZOLE FROM NAIL LACQUER FORMULATIONS THROUGH BOVINE HOOF<br />

MEMBRANE<br />

Alisa Elezović, Sabira Hadžović, Amar Elezović, Indira Mu<strong>je</strong>zin, Jasmina<br />

Hadžiabdić, Ogn<strong>je</strong>nka Rahić<br />

FTK-30 UTICAJ TEHNOLOŠKOG POSTUPKA NA STRUKTURU NEJONSKE AMBIFILNE<br />

PODLOGE<br />

THE INFLUENCE OF PREPARATION МЕТHOD ON THE STRUCTURE OF NONIONIC<br />

AMPHIPHILIC COMPOSITION<br />

Marija Toskić-Radojičić, Miljana Golubović, Emilija Gazikalović, Mirjana Boškivić,<br />

Aleksandra Aranđelović<br />

FTK-31 MAGISTRALNI LEKOVI SA UREOM, KALCIPOTRIOLOM I KOFEINOM U TERAPIJI<br />

PSORIJAZE I UTICAJ NA KVALITET ŽIVOTA PACIJENATA<br />

EXTEMPORARY PREPARED CREAMS CONTAINING UREA, CALCIPOTRIOL AND<br />

CAFFEINE IN THERAPY OF PSORIASIS AND IMPACT ON THE QUALITY OF LIFE OF<br />

PATIENTS WITH PSORIASIS<br />

Mirjana Gajdaš, Nataša Živanović, Filip Šer<br />

FTK-32 EX TEMPORE PRIPREMA I ISPITIVANJE INJEKCIJA CEFUROKSIM-NATRIJUM 10 mg/ml<br />

EX TEMPORE PREPARATION AND QUALITY EVALUATION OF CEFUROXIM-SODIUM<br />

INJECTION 10 mg/ml<br />

Dragana Aleksić, Mirjana Antunović, Vesna Putić, Dušica Mirković, Sonja Ćosić,<br />

Vladimir Draganić

FTK-33 A SURVEY ON BENZALKONIUM CHLORIDE ADSORPTION BY VARIOUS FILTER<br />

MEMBRANES FOR STERILE FILTRATION OF NAPHAZOLINE HYDROCHLORIDE EYE<br />

DROPS<br />

Dejan Kostovski, Sanja Simeonovska, Suzan Sejfulah, Irena Brashnarska,<br />

Sonja Ugarkovic<br />

FTK-34 FORMULACIJA I KARAKTERIZACIJA KAPI ZA OČI SA CIKLOSPORINOM A<br />

PRIPREMLJENIH EX TEMPORE IZ KOMERCIJALNIH PREPARATA<br />

FORMULATION AND CHARACTERIZATION OF CYCLOSPORINE A EYE DROPS PREPARED<br />

EXTEMPORANEOUSLY FROM CYCLOSPORINE A COMMERCIAL PRODUCTS<br />

Ljiljana Đekić, Jela Milić, Jasmina Drašković, Danina Krajišnik, Marija Primorac<br />

FTK-35 FORMULACIJA I KARAKTERIZACIJA KAPI ZA UŠI SA ETARSKIM ULJEM EUKALIPTUSA<br />

FORMULATION AND CHARACTERIZATION OF EAR DROPS WITH ESSENTIAL<br />

EUCALYPTUS OIL<br />

Slavica Milic, Jela Milic, Petar Milic, Niko Radulovic, Zoran Todorovic,<br />

Valentina Arsic-Arseni<strong>je</strong>vic<br />

FTK-36 UPRAVLJANJE PROJEKTOM VALIDACIJE FARMACEUTSKIH PROCESA U APOTECI<br />

BEOGRAD<br />

Studija slučaja: IZRADA ERITROMICIN RASTVORA ZA PRIMENU NA KOŽI<br />

PHARMACEUTICAL PROCESSES VALIDATION PROJECT MANAGEMENT IN THE<br />

"BELGRADE" COMMUNITY PHARMACY.<br />

Case study: PREPARATION OF ERYTHROMYCIN TOPICAL SOLUTION<br />

Nataša Živanović, Mirjana Gajdaš, Milanka Vico-Stevanović<br />

FTK-37 AKT O KATEGORIJI PROIZVODA KOJI SE IZDAJU U APOTEKAMA – ZAŠTO GA NEMA<br />

U SRBIJI?<br />

THE ACT ON THE CATEGORY OF PRODUCTS THAT ARE ISSUED IN PHARMACIES -<br />

WHY DOES NOT EXIST IN SERBIA?<br />

Gordana Vuleta, Radava Korać, Iva Zdravković<br />

FTK-38 PROIZVODNJA AKTIVNE SUPSTANCE – HUMANI ANTIRABIJSKI IMUNOGLOBULIN<br />

PRODUCTION OF ACTIVE SUBSTANCE – HUMAN ANTIRABIES IMMUNOGLOBULIN<br />

Dragica Vidanović, Branimir Kešin, Marina Sinđić Milićević, Nenad Vran<strong>je</strong>š,<br />

Verica Radovanović, Laura Balint<br />

FTK-39 ISPITIVANJE FLUIDNOSTI MEMBRANA RAZLIČITIH INVASOMA PRIMENOM<br />

ELEKTRON-SPIN REZONANCE<br />

INVESTIGATION OF FLUIDITY OF DIFFERENT INVASOMES BY ELECTRON SPIN<br />

RESONANCE<br />

Nina Dragicevic-Curic, Manfred Friedrich, Dani<strong>je</strong>la Pecarski, Winfried Plass,<br />

Alfred Fahr

SEKCIJA ZA TOKSIKOLOŠKU I SANITARNU HEMIJU (TSH)<br />

TOXICOLOGICAL AND SANITARY CHEMISTRY SECTION (TSH)<br />

TSH-1 PROFILAKTIČKI EFEKAT PRETRETMANA MAGNEZIJUMOM NA SADRŽAJ KADMIJUMA<br />

KOD MIŠEVA IZLOŽENIH AKUTNOM TROVANJU KADMIJUMOM<br />

PROPHYLACTIC EFFECT OF MAGNESIUM PRETREATMENT ON CADMIUM CONTENT<br />

IN MICE EXPOSED TO ACUTE CADMIUM INTOXICATION<br />

Dani<strong>je</strong>la Djukic-Ćosić, Zorica Bulat, Milica Ninković, Predrag Vukomanović,<br />

Živorad Maličević, Vesna Matović<br />

TSH-2 PROGRAM ZAŠTITE RADNE SREDINE OD UTICAJA ALKOHOLA I DRUGIH<br />

PSIHOAKTIVNIH SUPSTANCI<br />

PROTECTION PROGRAM OF OCCUPATIONAL ENVIRONMENT AGAINST ALCOHOL<br />

AND OTHER PSYCHOACTIVE SUBSTANCES<br />

Petra Milićević, Ana Vitković<br />

TSH-3 ASSESSMENT OF HEAVY METAL LEVELS IN SERUM SAMPLES OF PROFESSIONALLY<br />

EXPOSED WORKERS<br />

Darinka Gjorgieva, Katarina Smilkov, Biljana Gjorg<strong>je</strong>ska<br />

TSH-4 METAL CONTENT IN MEDICINAL PLANTS GROWING IN MACEDONIA<br />

Darinka Gjorgieva, Tatjana Kadifkova-Panovska, Katerina Baceva, Trajce Stafilov<br />

TSH-5 MONITORING OF HEAVY METAL POLLUTION USING PLANT ASSAY<br />

Darinka Gjorgieva, Tatjana Kadifkova-Panovska, Katerina Bačeva, Trajče Stafilov<br />

TSH-6 ZNAČAJ BIOLOŠKOG MONITORINGA<br />

THE IMPORTANCE OF BIOLOGICAL MONITORING<br />

Vladimir Nešić, Verica Uzelac<br />

TSH-7 ODREĐIVANJE OPIJATA U SALIVI I URINU KOD AKUTNO OTROVANIH ZAVISNIKA<br />

DETERMINATION OF OPIATES IN SALIVA AND URINE IN ACUTELY POISONED PATIENTS<br />

Biljana Ćirić, Vesna Kilibarda, Dragan Stojšić, Jasna Jović-Stošić<br />

TSH-8 KORELACIJE KONCETRACIJA DIAZEPAMA U SALIVI I SERUMU<br />

CORRELATION OF DIAZEPAM CONCENTRATIONS IN SALIVA AND SERUM<br />

Snežana Đorđević, Vesna Kilibarda, Slavica Vučinić, Biljana Antoni<strong>je</strong>vić,<br />

Ljubica Zamurović, Đorđe Ćurčić<br />

TSH-9 TOKSIKOLOŠKO-HEMIJSKE ANALIZE BIOLOŠKOG MATERIJALA U ODELJENJU ZA<br />

TOKSIKOLOŠKU HEMIJU CENTRA ZA KONTROLU TROVANJA VMA U PERIODU OD<br />

2006. DO 2009.<br />

TOXICOLOGICAL ANALYSIS OF BIOLOGICAL SAMPLES IN DEPARTMENT OF<br />

TOXICOLOGICAL CHEMISTRY POISON CONTROL CENTER MMA IN PERIOD<br />

FROM 2006. TO 2009.<br />

Snežana Đorđević, Gordana Brajković, Dragana Rančić, Dragan Stojšić,<br />

Milica Zlatković, Biljana Ćirić

TSH-10 PRAĆENJE SADRŽAJA ARSENA U VODAMA ZA PIĆE SREMA I MAČVE U PERIODU<br />

2004 - 2010.<br />

MONITORING OF ARSENIC IN DRINKING WATER OF SREM AND MACVA IN 2004 - 2010<br />

Žaklina Ljubičić, Biljana Antoni<strong>je</strong>vić, Vesna Matović<br />

TSH-11 MONITORING AFLATOKSINA B1 I OHRATOKSINA A U UZORCIMA NAMIRNICA<br />

MONITORING OF AFLATOXIN B1 AND OCHRATOXIN A IN FOOD SAMPLES<br />

Žaklina Ljubičić, Biljana Antoni<strong>je</strong>vić, Gorica Vuković, Marinela Tadić,<br />

Vesna Matović<br />

TSH-12 ODREĐIVANJE ETANOLA U KRVI METODOM GASNE HROMATOGRAFIJE U ODELJENJU<br />

ZA TOKSIKOLOŠKU HEMIJU CENTRA ZA KONTROLU TROVANJA VMA<br />

DETERMINATION OF ETHANOL IN BLOOD BY GAS CHROMATOGRAPHY IN<br />

DEPARTMENT OF TOXICOLOGICAL CHEMISTRY POISON CONTROL CENTER MMA<br />

Dragana Rančić, Gordana Brajković, Milica Zlatković, Vesna Kilibarda,<br />

Snežana Đorđević, Nadežda Krstić<br />

TSH-13 IDENTIFIKACIJA HEROINA U PREDMETIMA ZA SUDSKOMEDICINSKO VEŠTAČENJE<br />

U 2009 U ODELJENJU ZA TOKSIKOLOŠKU HEMIJU<br />

IDENTIFICATION OF HEROIN IN SAMPLES FOR FORENSIC EXPERTISE IN 2009 IN<br />

DEPARTMENT OF TOXICOLOGICAL CHEMISTRY<br />

Dragana Rančić<br />

TSH-14 O TOKSIČNOSTI SIBUTRAMINA<br />

ABOUT THE TOXICITY OF SIBUTRAMINE<br />

Aleksandra Buha, Zorica Bulat, Predrag Vukomanović, Vesna Matović<br />

TSH-15 SADRŽAJ FLUORIDA U INFUZIMA ZELENOG I CRNOG ČAJA KOJI SE NALAZE NA<br />

TRŽIŠTU SRBIJE<br />

FLUORIDE CONTENT IN TEA INFUSIONS AVAILABLE ON THE SERBIAN MARKET<br />

Aleksandra Repić, Vesna Milutinović, Zorica Blago<strong>je</strong>vić, Biljana Antoni<strong>je</strong>vić,<br />

Zorica Bulat,Vesna Matović<br />

TSH-16 DA LI PRIMENA MAGNEZIJUMA ILI CINKA UTIČE NA APSORPCIJU I ELIMINACIJU<br />

KADMIJUMA KOD KUNIĆA TROVANIH KADMIJUMOM?<br />

DOES MAGNESIUM OR ZINC SUPPLEMENTATION CHANGE CADMIUM ABSORPTION<br />

AND ELIMINATION IN RABBITS INTOXICATED WITH CADMIUM?<br />

Zorica Bulat, Dani<strong>je</strong>la Đukić-Ćosić, Petar Bulat, Zoran Pavlović, Dragana<br />

Vujanović, Vesna Matović<br />

TSH-17 SADRŽAJ FLUORIDA U ZUBIMA PACOVA IZLOŽENIH RAZLIČITIM KONCENTRACIJAMA<br />

FLUORIDA PUTEM VODE ZA PIĆE<br />

TEETH FLUORIDE LEVELS IN RATS EXPOSED TO DIFFERENT CONCENTRATIONS OF<br />

FLUORIDE IN DRINKING WATER<br />

Zoran Mandinić, Marijana Ćurčić, Biljana Antoni<strong>je</strong>vić, Momir Carević,<br />

Vesna Jaćević<br />

TSH-18 PROCENA NEDELJNOG UNOSA ODREĐENIH KONTAMINANATA PUTEM RIBE<br />

ESTIMATION OF WEEKLY INTAKE OF CERTAIN CONTAMINANTS BY FISH<br />

CONSUMPTION<br />

Saša Janković, Tatjana Radičević, Slavica Vesković, Marijana Ćurčić, Ksenija<br />

Durgo, Biljana Antoni<strong>je</strong>vić

TSH-19 OLOVO I ARSEN U DUVANU I GEOGRAFSKO POREKLO<br />

LEAD AND ARSENIC IN TOBACCO AND GEOGRAPHICAL ORIGIN<br />

Biljana Ljubenović, Jelena Videnović<br />

TSH-20 PREDLOŽENA METODA ZA ANALIZU PREKURSORA I LEKOVA KOJI SE<br />

ZLOUPOTREBLJAVAJU IZ EKSTRAKTA PUNE KRVI<br />

PROPOSED METHOD FOR SCREENING OF PRECURSORS AND DRUGS OF ABUSE<br />

FROM WHOLE BLOOD EXTRACT<br />

Katarina Vučićević-Prčetić, Sebastian Kujundžić<br />

TSH-21 PSIHOAKTIVNE SUPSTANCE KAO UZROK SMRTI: PODACI INSTITUTA ZA SUDSKU<br />

MEDICINU ZA PERIOD 2007-2009. GODINE<br />

PSYCHOACTIVE SUPSTANCES AS CAUSE OF DEATH: DATA REVIEW BY INSTITUTE OF<br />

FORENSIC MEDICINE, BELGRADE FOR PERIOD 2007-2009<br />

Anđelka Spasić, Vera Lukić, Milena Spasić<br />

TSH-22 ANALITIČKA POTVRDA ZLOUPOTREBE EFEDRINA KOD SPORTISTE PRIMENOM<br />

METODE TEČNE HROMATOGRAFIJE SA MS I PDA DETEKCIJOM: PRIKAZ SLUČAJA<br />

ANALYTICAL CONFIRMATION OF THE ABUSE OF EPHEDRINE IN ATHLETE USING<br />

THE METHOD OF LIQUID CHROMATOGRAPHY WITH PDA AND MS DETECTION:<br />

CASE REPORT<br />

Gordana Brajković, Dragana Rančić, Olivera Potrebić, Vesna Kilibarda,<br />

Snežana Đorđević, Milica Zlatković, Nadežda Krstić<br />

TSH-23 STATUS UHRANJENOSTI I KOMPONENTE METABOLIČKOG SINDROMA U PACIJENATA<br />

NA TERAPIJI ATIPIČNIM ANTIPSIHOTICIMA<br />

NUTRITIONAL STATUS AND COMPONENTS OF METABOLIC SYNDROME IN PATIENTS<br />

ON ATYPICAL ANTIPSYCHOTICS THERAPY<br />

Bojana Vidović, Brižita Đorđević, Čedo Mil<strong>je</strong>vić, Dušica Lečić-Toševski,<br />

Nikola Milašinović, Ivanka Miletić<br />

TSH-24 ODREĐIVANJE SADRŽAJA UKUPNIH POLIFENOLA U KOMERCIJALNIM PROIZVODIMA<br />

OD PLODA KAFE (COFFEA SP) I LISTA ČAJA (CAMELLIA SINENSIS) I NAPICIMA OD<br />

KAFE I LISTA ČAJA<br />

DETERMINATION OF TOTAL POLYPHENOLS IN COFFEE (COFFEA SP) AND TEA<br />

(CAMELLIA SINENSIS) PRODUCTS AND COFFEE AND TEA BEVERAGES<br />

Jelena Slavković, Slađana Šobajić, Tamara Milošević, Maja Pekić,<br />

Tatjana Kundaković<br />

TSH-25 KORELACIJA UNOSA MLEKA I MLEČNIH PROIZVODA SA INDEKSOM TELESNE MASE U<br />

STUDENTSKOJ POPULACIJI<br />

ASSOCIATION BETWEEN TOTAL DAIRY INTAKE AND BMI IN STUDENT POPULATION<br />

Milica Ćulafić, Nevena Medaković, Sladjana Šobajić, Ivana Djuričić<br />

TSH-26 UNOS DIJETNIH VLAKANA U ISHRANI PREDŠKOLSKE DECE: KOMPARACIJA<br />

ENZIMSKO-GRAVIMETRIJSKE I SCHARER-KURCHNEROVE METODE<br />

INTAKE OF DIETARY FIBERS WITHIN COLLECTIVE NUTRITION OF PRESCHOOL<br />

CHILDREN: ENZYME-GRAVIMETRIC AND SCHARER-KURCHNER - METHODS'<br />

COMPARISON<br />

Nataša Đukić, Slađana Šobajić, Ivanka Miletić, Gordana Vraštanović Pavićević

TSH-27 SADRŽAJ SELENA U NAMIRNICAMA ŽIVOTINJSKOG POREKLA SELENIUM CONTENT IN<br />

FOOD OF ANIMAL ORIGIN<br />

Zoran Pavlović, Ivanka Miletić, Živan Jokić, Slađana Šobajić<br />

TSH-28 REZISTENTAN SKROB I CELULOZA – NAJZNAČAJNIJA VLAKNA U PRAVILNO<br />

DIZAJNIRANOJ ISHRANI<br />

RESISTANT STARCH AND CELLULOSE - THE MOST IMPORTANT FIBER IN OPTIMALLY<br />

DESIGNED DIET<br />

Margarita Dodevska, Ivanka Miletić, Brižita Đorđević, Jelena Kotur-Stevul<strong>je</strong>vić,<br />

Predrag Đorđević, Milan Simić<br />

TSH-29 PROBIOTIČKE OSOBINE PRIRODNOG LACTOBACILLUS SP. IZOLATA HUMANOG<br />

POREKLA<br />

PROBIOTIC PROPERTIES OF THE NATURAL, HUMAN LACTOBACILLUS SP. ISOLATE<br />

Jelena Novaković Jovanović, Svetlana Seatović, Valentina Vranić, Zeljka<br />

Radulović, Gordana Zavišić<br />

TSH-30 KONTROLA SADRŽAJA JODA U SOLI ZA LJUDSKU ISHRANU<br />

CONTROL OF SALT AS A SOURCE OF IODINE<br />

Konstansa Lazarević, Dejan Nikolic<br />

TSH-31 ODREĐIVANJE SADRŽAJA KOENZIMA Q10 U UZORCIMA DIJETETSKIH SUPLEMENATA<br />

METODOM VISOKO-EFIKASNE TEČNE HROMATOGRAFIJE SA UV DETEKCIJOM<br />

DETERMINATION OF COENZYME Q10 IN DIETARY SUPPLEMENTS WITH<br />

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH UV DETECTION<br />

Maja Mijačić, Milan Maksimović<br />

TSH-32 ODREĐIVANJE TARTRAZINA, SUNSET YELLOW I AZORUBINA U INSTANT<br />

OSVEŽAVAJUĆIM BEZALKOHOLNIM PIĆIMA TANKOSLOJNOM HROMATOGRAFIJOM<br />

DETERMINATION OF TARTRAZINE, SUNSET YELLOW AND AZORUBINE IN INSTANT<br />

SOFT DRINKS BY THIN-LAYER CHROMATOGRAPHY<br />

Marija Stanković<br />

TSH-33 ODREĐIVANJE UKUPNE SAPONIFIKUJUĆE MATERIJE U SAPUNIMA GRAVIMETRIJSKOM<br />

METODOM I POTENCIOMETRIJSKI DVOFAZNOM TITRACIJOM-POREĐENJE METODA<br />

COMPARATION OF DETERMINATION OF TOTAL FATTY MATTER IN SOAPS BY<br />

GRAVIMETRIC METHOD AND POTENTIOMETRIC TWO-PHASE TITRATION<br />

Ana Stanisavl<strong>je</strong>v, Marija Stanković, Gorica Vuković, Marinela Tadić<br />

TSH-34 ODREĐIVANJE SIBUTRAMINA U DIJETETSKIM PROIZVODIMA METODOM TEČNE<br />

HROMATOGRAFIJE TANDEM-MASENE SPEKTROMETRIJE (LC-MS/MS) DETERMINATION<br />

OF SIBUTRAMINE IN DIETARY PRODUCTS FROM SERBIAN MARKET BY LIQUID<br />

CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY<br />

Gorica Vuković, Marinela Tadić, Marija Cindrić, Marija Stanković<br />

TSH-35 ODREĐIVANJE SADRŽAJA SIBUTRAMINA U UZORCIMA DIJETETSKIH SUPLEMENATA<br />

ZELENE KAFE METODAMA VISOKO EFIKASNE TEČNE HROMATOGRAFIJE SA UV I<br />

MS DETEKCIJOM<br />

DETERMINATION OF SIBUTRAMINE CONTENT IN SOME DIETARY SUPPLEMENT<br />

SAMPLES WITH GREEN COFFEE EXTRACTS BY HIGH PERFORMANCE LIQUID<br />

CHROMATOGRAPHY WITH UV AND MASS SPECTROMETRY DETECTION<br />

Maja Mijačić, Milan Maksimović, Milica Zlatković

TSH-36 ISPITIVANJE BIOSORBENTA ZA SPECIJACIONU ANALIZU HROMA IZ VODENIH<br />

RASTVORA<br />

EVALUATION OF BIOSORBENT FOR CHROMIUM SPECIATION ANALYSIS FROM<br />

AQUEOUS SOLUTIONS<br />

Anka Nedić, Danka Ristović, Brižita Đorđević, Katarina Karljiković-Rajić<br />

TSH-37 ODREĐIVANJE OLOVA, ŽIVE I KADMIJUMA U RUŽEVIMA ZA USNE PORJEKLOM IZ<br />

KINE PRISUTNIM NA TRŽIŠTU BOSNE I HERCEGOVINE<br />

LEAD, MERCURY AND CADMIUM IN LIPSTICKS OF CHINESE ORIGIN PRESENT ON<br />

THE MARKET OF BOSNIA AND HERZEGOVINA<br />

Miroslav Šober, Elma Makarević, Amra Hrvat, Mirza Dedić, Jasmin Migalo,<br />

Saira Medanhodžić-Vuk<br />

TSH-38 ANALIZA KAŠIRANIH I JEDNOSLOJNIH POLIMERNIH AMBALAŽNIH FOLIJA ZA<br />

ŽIVOTNE NAMIRNICE<br />

ANALYSIS OF LAYERED AND SINGLE-LAYERED POLYMER FOOD PACKAGING FOILS<br />

Marija Đorđević<br />

TSH-39 SPEKTROFOTOMETRIJSKO ODREĐIVANJE ANTIOKSIDANTNIH OSOBINA IZABRANIH<br />

SORTI VINA SRBIJE<br />

SPECTROPHOTOMETRIC DETERMINATION OF ANTIOXIDATIVE CAPACITY OF<br />

SELECTED TYPES OF SERBIAN WINES<br />

Čakar Uroš, Čakar Nataša, Brižita Đorđević, Bojana Vidović

Mesto održavanja / Congress Venue

Izložba / Exibition

OPSTE INFORMACIJE / GENERAL INFORMATION<br />

Mesto odrzavanja / Venue<br />

Sava centar / Congress Centre Sava<br />

13 - 17. oktobar 2010. / October 13 - 17, 2010<br />

www.savacentar.com<br />

Zvanicni <strong>je</strong>zik / Official languages<br />

Srpski i engleski / Serbian and English<br />

Prevod ni<strong>je</strong> obezbeden / Translation is not provided<br />

Registracija ucesnika / Registration of participants<br />

Registracija ucesnika i dodatne informaci<strong>je</strong> bice dostupne na Registracionom pultu u<br />

Kongresnom Centru Sava / Registration and information: Registration Desk, Sava Congress<br />

Center<br />

13.10.2010. 14:00 - 19:00<br />

14.10.2010. 08:30 - 18:00<br />

15.10.2010. 08:30 - 18:00<br />

16.10.2010. 08:30 - 15:00<br />

Bedzevi i ulaznice / Badges and entrance tickets<br />

Prilikom registraci<strong>je</strong> svaki ucesnik dobija finalni program, elektronsku verziju casopisa Arhiv<br />

za farmaciju i bedz koji <strong>je</strong> potrebno nositi u toku trajanja Kongresa. Prisustvo radnom delu i<br />

drugim kongresnim sadrzajima nece biti moguce bez bedza.<br />

Kotizacija za pratecu osobu ne ukljucu<strong>je</strong> kongresni materijal i potvrdu o ucescu.<br />

Every participant will receive the Final Programme, an electronic version of the Journal Arhiv<br />

za farmaciju and a Congress badge which should be worn during the Congress. Attendance to<br />

the working part and all other Congress events will not be possible without a badge.<br />

Registration fee for accompanying persons does not cover congress materials and certificate<br />

of attendance.<br />

Izložba / Exhibition<br />

Izložba farmaceutske industi<strong>je</strong> i medicinske opreme biće otvorena za vreme trajanja<br />

naučnog dela Kongresa u holu ispred Plave dvorane.<br />

The exhibition of pharmaceutical and medical equipment will be opened during the scientific<br />

program in the exhibition area - in front of the Blue hall.

Tehničke mogućnosti / Technical support<br />

U salama za rad su obezbeđeni tehnički uslovi za kompjutersku prezentaciju. Potrebno <strong>je</strong> da<br />

prezentaci<strong>je</strong> budu pripreml<strong>je</strong>ne u programu MS Power Point i dostavl<strong>je</strong>ne na CD-u, USB<br />

memoriji ili na sopstvenom notebook računaru.<br />

Technical equipment for presentations is provided in working halls. Presentations in MS Power<br />

Point should be delivered on CD, USB memory or on own notebook.<br />

Prezentacija radova / Types of presentation<br />

Vreme za plenarna izlaganja <strong>je</strong> do 30 minuta.<br />

Vreme za predavan<strong>je</strong> po pozivu <strong>je</strong> od 20 do 30 minuta.<br />

Vreme za usmena izlaganja <strong>je</strong> do 15 minuta.<br />

Maksimalne dimenzi<strong>je</strong> postera su 1m x 1.2 m. Posteri će biti izloženi u Sali/prostoru za poster<br />

prezentaci<strong>je</strong>. Planirana <strong>je</strong> poster diskusija u okviru sekcija kao i dodela nagrada za najbol<strong>je</strong><br />

poster radove.<br />

Plenary introductory lecture (30 minutes)<br />

Invited lecturers (20 -30 minutes)<br />

Oral presentation (10 -15 minutes)<br />

Poster persentation: max. dimension 1 m x 1.2 m. Posters will be displayed in the Posters hall.<br />

A poster discussion is planned within sections, followed by awards for the best posters.<br />

Potvrda o učestvovanju / Certificates of attendance<br />

Registrovani učesnici mogu podići potvrdu o učešću na registracionom pultu u subotu<br />

16.10.2010. od 13:00h.<br />

Registered participants can collect Certificates of attendance at the Registration desk on<br />

Saturday, 16 October from 13:00h.

DRUSTENI PROGRAM / SOCIAL PROGRAMME<br />

Sreda / Wednesday<br />

13. oktobar 2010. / October 13, 2010 - 18:00<br />

Plava dvorana Sava centra / Blue hall, Sava Center<br />

Svečano otvaran<strong>je</strong> / Opening Ceremony<br />

Petak / Friday<br />

15. oktobar 2010. / October 15, 2010 - 20:30h<br />

Plava dvorana Sava centra/ Blue hall, Sava Center<br />

Koncert Bil<strong>je</strong> Krstic/ Concert of Bilja Krstic<br />

Agencija za lekove i medicinska sredstva Srbi<strong>je</strong> vas poziva na koncert koji ce odrzati<br />

Bilja Krstic i ansambl "Bistrik"<br />

Pozdravna rec: Mr. farm. spec. Tatjana Sipetic, direktorka Agenci<strong>je</strong> za lekove i medicinska<br />

sredstva Srbi<strong>je</strong><br />

The Agency for Medicinal Products and Medical Devices of Serbia has the honour to invite<br />

you to the concert of Bilja Krstić and the "Bistrik" ensemble.<br />

Welcome word: by Mr. pharm. spec. Tatjana Šipetić, director of the Agency for Medicinal<br />

Products and Medical Devices of Serbia<br />

Subota / Saturday<br />

16. oktobar 2010. / October 16, 2010 - 20:00h<br />

Svecana vecera / Gala Dinner<br />

Restoran Sava / Restaurant Sava<br />

Vauceri se preuzimaju prilikom registraci<strong>je</strong>.<br />

Vouchers are issued at the Registration desk.<br />

Ručak i kafe pauze / Lunch and coffee breaks<br />

Za vreme trajanja Kongresa učesnici sa plaćenom kotizacijom imaju pravo na 1 sendvič i<br />

2 kafe dnevno, za ko<strong>je</strong> će dobiti vaučere prilikom registraci<strong>je</strong>.<br />

Kafa će se služiti 14, 15 i 16. oktobra od 10:00 -12:00 i od 16:00 -18:00 u Art café-u<br />

Sendviči će se služiti 14, 15 i 16. oktobra od 13:00 -15:00 u Art café-u.<br />

Registered participants will receive at the Registration desk vouchers for 1 sandwich and<br />

2 coffees per day to be used during the Congress.<br />

Coffee will be served on October 14, 15 and 16 from 10:00 -12:00h and 16:00 -18:00h<br />

in the ART Cafe.<br />

Sandwiches will be served on October 14, 15 and 16 from 13:00 -15:00h in the ART Cafe.

Smeštaj / Accommodation<br />

Ucesnici Kongresa bice smesteni u sledecim hotelima:<br />

The participants of the Congress will be accommodated in following hotels:<br />

HOTEL CONTINENTAL<br />

Vladimira Popovica 10, Novi Beograd<br />

Telefon: 220 4204<br />

IN HOTEL<br />

Bul. Arsenija Carno<strong>je</strong>vica 56<br />

Telefon: 310 5354<br />

MOSKVA<br />

Balkanska 1, Beograd<br />

Telefon: 268 6255<br />

PARK<br />

N<strong>je</strong>goševa 4, Beograd<br />

Telefon: 364 0393<br />

KASINA<br />

Terazi<strong>je</strong> 25, Beograd<br />

(centar, do Intercontinentala vozi autobus br. 95)<br />

Telefon: 323 5574<br />

PALACE<br />

Topličin venac 23, Beograd<br />

Telefon: 218 5585<br />

Važne adrese / Important addresses<br />

Naučni odbor, Organizacioni odbor, Sekretarijat Kongresa<br />

The Scientific Committee, the Organizing Committee,<br />

The Secretariate of the Congress<br />

Farmaceutsko društvo Srbi<strong>je</strong> / Pharamceutical Society of Serbia<br />

11000 Beograd, Bulevar vojvode Mišića 25<br />

Telefon: +381 11 2648 385<br />

Faks: +381 11 2648 385<br />

e-mail: fds@sbb.rs<br />

www.farmacija.org<br />

Izvršni organizator<br />

Executive organizer<br />

Smart Travel<br />

Licenca OTP 144/2010<br />

11000 Beograd, Sv. Save 43/I<br />

Telefoni: +381 11 308 6694, 308 7487<br />

Faks: +381 11 308 6695<br />

e-mail: smart4@eunet.rs<br />

www.smart4.co.rs

ZAHVALJUJEMO NA POMOĆI U ORGANIZACIJI KONGRESA<br />

WE THANK FOR THE SUPPORT IN THE ORGANISATION OF THE CONGRESS<br />

GALENIKA<br />

Agencija za lekove i medicinska sredstva Srbi<strong>je</strong><br />

PHARMANOVA<br />

FARMALOGIST<br />

A LEK<br />

ACTAVIS<br />

ALKALOID<br />

BAYER<br />

BEIERSDORF<br />

BERLIN CHEMIE MENARINI<br />

Boehringer Ingelheim Serbia<br />

BONIFAR<br />

BOSNALIJEK Predstavništvo Beograd<br />

DR THEISS NATURWAREN<br />

DRAGIS-PHARM<br />

ELEPHANT PHARMA<br />

Farmaceutska komora Srbi<strong>je</strong><br />

GlaxoSmithKline<br />

IVANČIĆ<br />

Institut za proučavan<strong>je</strong> lekovitog bilja "Dr JOSIF PANČIĆ"<br />

Jadran Galenski Laboratorij Ri<strong>je</strong>ka<br />

JAMAX M<br />

JUGOHEMIJA FARMACIJA<br />

KIBID<br />

KIRKA CORPORATION<br />

MCG GROUP<br />

Predstavništvo MEDA Pharmaceuticals Switzerland GmbH<br />

MERCK<br />

MINISTARSTVO<br />

MIP-PHARMA<br />

MERCK SHARP&DOHME<br />

SCHERING PLOUGH CENTRAL EAST AG<br />

MULTIPHARM PLUS<br />

NELT CO<br />

NOBEL ILAC SANAZYII VE TICARET A.S.<br />

NORDVIK<br />

NYCOMED GmbH<br />

PHARMASWISS<br />

RICHTER GEDEON<br />

SANDOZ PHARMACEUTICAL<br />

SANOFI AVENTIS<br />

SUPPLEMENT<br />

SWISS HEALTH

Notes

logo

Prodotti

Risorse

Aziende

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!